
  
    
      
        Background_NNP
        The_DT overuse_NN of_IN antibiotics_NNS in_IN the_DT clinic_NN and_CC for_IN
        agricultural_JJ uses_VBZ has_VBZ resulted_VBN in_IN a_DT tremendous_JJ selective_JJ
        pressure_NN for_IN antibiotic_JJ resistant_JJ bacteria_NNS ._. These_DT bacteria_NNS
        become_VBP resistant_JJ by_IN a_DT number_NN of_IN mechanisms_NNS ,_, such_JJ as_IN
        producing_VBG enzymes_NNS that_WDT hydrolyze_NN or_CC inactivate_NN the_DT
        antibiotics_NNS ,_, producing_VBG efflux_NN pumps_NNS that_WDT transport_NN the_DT
        antibiotic_NN out_IN of_IN the_DT cell_NN ,_, or_CC modifying_VBG their_PRP$ cell_NN wall_NN
        components_NNS so_IN they_PRP no_RB longer_JJR bind_NN effectively_RB to_TO the_DT
        antibiotics_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._. The_DT most_RBS common_JJ ,_, least_JJS expensive_JJ ,_,
        and_CC effective_JJ antibiotics_NNS are_VBP the_DT β-lactam_JJ containing_VBG
        antibiotics_NNS ,_, such_JJ as_IN the_DT penicillins_NNS ,_, cephalosporins_NNS ,_, and_CC
        carbapenems_NNS [_NN 2_CD 4_CD 5_CD ]_NN ._. These_DT antibiotics_NNS are_VBP
        mechanism-based_JJ inhibitors_NNS of_IN transpeptidase_NN ,_, a_DT bacterial_JJ
        enzyme_NN required_VBN for_IN the_DT production_NN of_IN a_DT strong_JJ viable_JJ cell_NN
        wall_NN [_NN 6_CD 7_CD ]_NN ._. In_IN response_NN to_TO the_DT widespread_JJ use_NN of_IN
        β-lactam_JJ containing_VBG antibiotics_NNS ,_, bacteria_NNS have_VBP acquired_VBN the_DT
        ability_NN to_TO produce_VB β-lactamases_JJ ,_, which_WDT are_VBP enzymes_NNS that_WDT
        hydrolyze_NN and_CC inactivate_NN β-lactam_JJ containing_VBG antibiotics_NNS ._.
        There_RB are_VBP over_IN 300_CD distinct_JJ β-lactamases_JJ known_VBN ,_, and_CC these_DT
        enzymes_NNS have_VBP been_VBN grouped_VBN by_IN a_DT number_NN of_IN classification_NN
        schemes_NNS [_NN 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD 14_CD 15_CD ]_NN ._. For_IN example_NN ,_, Bush_NNP has_VBZ
        developed_VBN a_DT scheme_NN ,_, based_VBN on_IN the_DT enzymes_NNS '_POS molecular_JJ
        properties_NNS ,_, that_WDT has_VBZ four_CD distinct_JJ β-lactamase_JJ groups_NNS [_NN 10_CD
        15_CD ]_NN ._. One_CD of_IN the_DT more_RBR alarming_JJ groups_NNS are_VBP the_DT Bush_NNP group_NN 3_CD
        enzymes_NNS ,_, which_WDT are_VBP Zn_NNP (_( II_NNP )_) dependent_JJ enzymes_NNS that_WDT hydrolyze_NN
        nearly_RB all_DT known_VBN β-lactam_JJ containing_VBG antibiotics_NNS and_CC for_IN
        which_WDT there_EX are_VBP no_DT or_CC very_RB few_JJ known_VBN clinical_JJ inhibitors_NNS [_NN
        9_CD 14_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._. The_DT metallo-β-lactamases_JJ have_VBP been_VBN
        further_RBR divided_VBN by_IN Bush_NNP into_IN subgroups_NNS based_VBN on_IN amino_JJ acid_NN
        sequence_NN identity_NN :_: the_DT Ba_NNP enzymes_NNS share_VBP a_DT >_NN 23_CD %_NN sequence_NN
        identity_NN ,_, require_VB 2_CD Zn_NNP (_( II_NNP )_) ions_NNS for_IN full_JJ activity_NN ,_, prefer_VBP
        penicillins_NNS and_CC cephalosporins_NNS as_IN substrates_NNS ,_, and_CC are_VBP
        represented_VBN by_IN metallo-β-lactamase_JJ CcrA_NNP from_IN 
        Bacteroides_NNP fragilis_NNS ,_, the_DT Bb_NNP enzymes_NNS
        share_VBP a_DT 11_CD %_NN sequence_NN identity_NN with_IN the_DT Ba_NNP enzymes_NNS ,_, require_VB
        only_RB 1_CD Zn_NNP (_( II_NNP )_) ion_NN for_IN full_JJ activity_NN ,_, prefer_VBP carbapenems_NNS as_IN
        substrates_NNS ,_, and_CC are_VBP represented_VBN by_IN the_DT metallo-β-lactamase_JJ
        imiS_NN from_IN 
        Aeromonas_NNP sobria_NN ,_, and_CC the_DT Bc_NNP enzymes_NNS
        have_VBP only_RB 9_CD conserved_JJ residues_NNS with_IN the_DT other_JJ
        metallo-β-lactamases_JJ ,_, require_VB 2_CD Zn_NNP (_( II_NNP )_) ions_NNS for_IN activity_NN ,_,
        contain_VBP a_DT different_JJ metal_NN binding_JJ motif_NN than_IN the_DT other_JJ
        metallo-β-lactamases_JJ ,_, prefer_VBP penicillins_NNS as_IN substrates_NNS ,_, and_CC
        are_VBP represented_VBN by_IN the_DT metallo-β-lactamase_JJ L_NNP 1_CD from_IN 
        Stenotrophomonas_NNP maltophilia_NN [_NN 9_CD ]_NN ._.
        A_DT similar_JJ grouping_VBG scheme_NN (_( B_NNP 1_CD ,_, B_NNP 2_CD ,_, and_CC B_NNP 3_LS )_) based_VBN on_IN
        structural_JJ properties_NNS of_IN the_DT metallo-β-lactamases_JJ has_VBZ
        recently_RB been_VBN offered_VBN [_NN 41_CD ]_NN ._. The_DT diversity_NN of_IN the_DT group_NN 3_CD
        β-lactamases_JJ is_VBZ best_RBS exemplified_VBN by_IN the_DT enzymes_NNS '_POS vastly_RB
        differing_VBG efficacies_NNS towards_IN non-clinical_JJ inhibitors_NNS ;_: these_DT
        differences_NNS predict_VBP that_IN one_CD inhibitor_NN may_MD not_RB inhibit_VB all_DT
        metallo-β-lactamases_JJ [_NN 18_CD 20_CD 21_CD 22_CD 23_CD 24_CD 25_CD 26_CD 27_CD 28_CD 29_CD ]_NN ._.
        To_TO combat_VB this_DT problem_NN ,_, we_PRP are_VBP characterizing_VBG a_DT
        metallo-β-lactamase_JJ from_IN each_DT of_IN the_DT subgroups_NNS in_IN an_DT effort_NN
        to_TO identify_VB a_DT common_JJ structural_JJ or_CC mechanistic_JJ aspect_NN of_IN
        the_DT enzymes_NNS that_WDT can_MD be_VB targeted_VBN for_IN the_DT generation_NN of_IN an_DT
        inhibitor_NN ._. It_PRP is_VBZ hoped_VBN that_IN this_DT inhibitor_NN ,_, when_WRB given_VBN in_IN
        combination_NN with_IN an_DT existing_VBG antibiotic_JJ ,_, will_MD prove_VB to_TO be_VB
        an_DT effective_JJ therapy_NN against_IN bacteria_NNS that_WDT produce_VBP a_DT
        metallo-β-lactamase_JJ ._. This_DT work_NN describes_VBZ our_PRP$ efforts_NNS on_IN
        metallo-β-lactamase_JJ L_NNP 1_CD from_IN 
        S_NNP ._. maltophilia_NN ._. 
        
        S_NNP ._. maltophilia_NN is_VBZ an_DT important_JJ
        pathogen_NN in_IN nosocomial_NN infections_NNS of_IN immunocompromised_JJ
        patients_NNS suffering_VBG from_IN cancer_NN ,_, cystic_JJ fibrosis_NNS ,_, drug_NN
        addition_NN ,_, AIDS_NNP and_CC in_IN patients_NNS with_IN organ_NN transplants_NNS and_CC
        on_IN dialysis_NN [_NN 30_CD 31_CD 32_CD ]_NN ._. This_DT organism_NN is_VBZ inherently_RB
        resistant_JJ to_TO most_JJS antibiotics_NNS due_JJ to_TO its_PRP$ low_JJ outer_JJ membrane_NN
        permeability_NN [_NN 33_CD ]_NN and_CC to_TO β-lactam_JJ containing_VBG antibiotics_NNS
        due_JJ to_TO the_DT production_NN of_IN a_DT chromosomally_RB expressed_VBN group_NN 2_CD e_SYM
        β-lactamase_JJ (_( L_NNP 2_LS )_) and_CC a_DT group_NN 3_CD c_SYM β-lactamase_JJ (_( L_NNP 1_LS )_) [_NN 34_CD 35_CD ]_NN
        ._. L_NNP 1_CD has_VBZ been_VBN cloned_VBN ,_, over-expressed_JJ ,_, and_CC partially_RB
        characterized_VBN by_IN kinetic_JJ and_CC crystallographic_JJ studies_NNS [_NN 36_CD
        37_CD ]_NN ._. The_DT enzyme_NN exists_VBZ as_IN a_DT homotetramer_NN of_IN 
        ca_MD ._. 118_CD kDa_NN in_IN solution_NN and_CC in_IN the_DT
        crystalline_JJ state_NN ._. The_DT enzyme_NN tightly_RB binds_NNS two_CD Zn_NNP (_( II_NNP )_) ions_NNS
        per_IN subunit_NN and_CC requires_VBZ both_DT Zn_NNP (_( II_NNP )_) ions_NNS for_IN full_JJ
        catalytic_JJ activity_NN ._. The_DT Zn_NNP 
        1_CD site_NN has_VBZ 3_CD histidine_NN residues_NNS and_CC 1_CD
        bridging_VBG hydroxide_NN as_IN ligands_NNS ,_, and_CC the_DT Zn_NNP 
        2_CD site_NN has_VBZ 2_CD histidines_NNS ,_, 1_CD aspartic_JJ
        acid_NN ,_, 1_CD terminally-bound_JJ water_NN ,_, and_CC the_DT bridging_VBG hydroxide_NN
        as_IN ligands_NNS ._. Spencer_NNP and_CC coworkers_NNS used_VBD the_DT crystal_NN
        structure_NN and_CC modeling_NN studies_NNS to_TO propose_VB a_DT substrate_NN
        binding_JJ model_NN and_CC identified_VBN several_JJ active_JJ site_NN residues_NNS
        that_WDT were_VBD involved_VBN in_IN substrate_NN binding_JJ (_( Figure_NN 1_LS )_) [_NN 37_CD ]_NN ._.
        However_RB ,_, this_DT model_NN has_VBZ not_RB been_VBN tested_VBN experimentally_RB ._. In_IN
        order_NN to_TO prepare_VB tight_JJ binding_JJ inhibitors_NNS of_IN the_DT
        metallo-β-lactamases_JJ ,_, knowledge_NN about_IN how_WRB substrate_NN binds_NNS
        to_TO the_DT enzymes_NNS is_VBZ needed_VBN so_IN that_IN all_DT substrate-enzyme_JJ
        binding_JJ contacts_NNS can_MD be_VB maintained_VBN in_IN any_DT proposed_VBN
        inhibitor_NN ._. This_DT work_NN describes_VBZ our_PRP$ efforts_NNS at_IN understanding_NN
        how_WRB substrates_NNS bind_NN to_TO metallo-β-lactamase_JJ L_NNP 1_CD ._. Several_JJ
        site-directed_JJ mutants_NNS of_IN L_NNP 1_CD were_VBD generated_VBN and_CC
        characterized_VBN ,_, and_CC the_DT results_NNS from_IN these_DT studies_NNS reveal_VBP
        that_DT none_NN of_IN the_DT active_JJ site_NN residues_NNS predicted_VBD from_IN
        earlier_JJR computational_NN studies_NNS [_NN 37_CD ]_NN are_VBP essential_JJ for_IN
        tight_JJ substrate_NN binding_JJ ._.
      
      
        Results_NNS
        
          Wild_NNP type_NN L_NNP 1_CD
          Wild-type_NNP L_NNP 1_CD was_VBD over-expressed_JJ in_IN 
          Escherichia_NNP coli_NNS and_CC purified_JJ as_IN
          previously_RB described_VBD [_NN 36_CD ]_NN ._. This_DT procedure_NN produced_VBD an_DT
          average_NN of_IN 50_CD -_: 60_CD mg_NN of_IN >_NN 90_CD %_NN pure_JJ ,_, active_JJ protein_NN per_IN 4_CD
          L_NNP of_IN growth_NN culture_NN ._. Circular_NNP dichroism_NN spectra_NN were_VBD
          collected_VBN on_IN wild-type_JJ samples_NNS to_TO ensure_VB L_NNP 1_CD expressed_VBD
          using_VBG the_DT pET_NN 26_CD b_SYM expression_NN system_NN had_VBD the_DT correct_JJ
          secondary_JJ structure_NN ._. The_DT CD_NNP spectrum_NN of_IN wild_JJ type_NN L_NNP 1_CD
          showed_VBD an_DT intense_JJ ,_, broad_JJ feature_NN at_IN 190_CD nm_NN and_CC a_DT smaller_JJR
          feature_NN at_IN 215_CD nm_NN (_( see_VB Additional_JJ file_NN 1_CD :_: CD_NNP spectra_NN )_) ._.
          These_DT features_NNS are_VBP consistent_JJ with_IN a_DT sample_NN with_IN
          significant_JJ α_NN /_NN β_NN content_NN ._. The_DT Compton_NNP and_CC Johnson_NNP
          algorithm_NN [_NN 38_CD ]_NN was_VBD used_VBN to_TO estimate_VB secondary_JJ structure_NN
          in_IN the_DT samples_NNS ;_: wild-type_JJ L_NNP 1_CD was_VBD estimated_VBN to_TO have_VB 38_CD ._. 3_LS %_NN
          α-helix_JJ ,_, 26_CD ._. 7_CD %_NN β-structure_JJ (_( 9_CD ._. 3_LS %_NN antiparallel_NN β-sheet_JJ ,_,
          2_CD ._. 1_CD %_NN parallel_JJ β-sheet_JJ ,_, and_CC 15_CD ._. 3_LS %_NN β-turn_JJ )_) ,_, and_CC 34_CD ._. 9_CD %_NN other_JJ
          structure_NN ._. These_DT estimates_NNS are_VBP in_IN excellent_JJ agreement_NN
          with_IN the_DT crystallographically_RB determined_VBN secondary_JJ
          structure_NN of_IN ~_NN 40_CD %_NN α-helix_JJ and_CC 30_CD %_NN β-structure_JJ [_NN 37_CD ]_NN ._.
          Metal_NNP analyses_NNS on_IN multiple_JJ preparations_NNS of_IN wild-type_JJ L_NNP 1_CD
          demonstrated_VBN that_IN the_DT enzyme_NN binds_NNS 1_CD ._. 9_CD ±_NN 0_CD ._. 2_CD Zn_NNP (_( II_NNP )_) ions_NNS
          per_IN monomer_NN (_( Table_NNP 2_LS )_) ,_, in_IN agreement_NN with_IN previous_JJ results_NNS
          [_NN 36_CD ]_NN ._.
          Steady_NNP state_NN kinetic_JJ studies_NNS were_VBD performed_VBN on_IN
          multiple_JJ preparations_NNS of_IN wild_JJ type_NN L_NNP 1_CD ,_, and_CC the_DT resulting_VBG
          kinetic_JJ data_NNS are_VBP shown_VBN in_IN Tables_NNP 3_CD ,_, 4_CD ,_, 5_CD ._. When_WRB using_VBG
          nitrocefin_NN as_IN substrate_NN and_CC 50_CD mM_NN cacodylate_NN ,_, pH_NN 7_CD ._. 0_CD ,_, as_IN
          buffer_NN ,_, wild-type_JJ L_NNP 1_CD exhibited_VBN a_DT 
          k_NN 
          cat_NN value_NN of_IN 38_CD ±_NN 1_CD s_VBZ -_: 1_CD and_CC a_DT K_NNP 
          m_NN value_NN of_IN 12_CD ±_NN 1_CD μM_NN ._. The_DT inclusion_NN of_IN
          100_CD μM_NN ZnCl_NNP 
          2_CD in_IN the_DT assay_NN buffer_NN resulted_VBD in_IN
          slightly_RB lower_JJR values_NNS of_IN K_NNP 
          m_NN and_CC higher_JJR values_NNS for_IN 
          k_NN 
          cat_NN [_NN 36_CD ]_NN ._. The_DT inclusion_NN of_IN higher_JJR
          concentrations_NNS of_IN Zn_NNP (_( II_NNP )_) did_VBD not_RB further_JJ affect_NN the_DT
          steady-state_JJ kinetic_JJ constants_NNS ._. Apparently_RB ,_, the_DT purified_JJ ,_,
          recombinant_JJ enzyme_NN does_VBZ not_RB bind_NN its_PRP$ full_JJ complement_VB of_IN
          Zn_NNP (_( II_NNP )_) ;_: therefore_RB ,_, 100_CD μM_NN Zn_NNP (_( II_NNP )_) was_VBD included_VBN in_IN all_DT
          subsequent_JJ kinetic_JJ studies_NNS ._.
          Wild-type_NNP L_NNP 1_CD exhibited_VBN 
          k_NN 
          cat_NN values_NNS of_IN 41_CD ±_NN 1_CD s_VBZ -_: 1_CD ,_, 1_CD ._. 9_CD ±_NN 0_CD ._. 1_CD s_VBZ
          -_: 1_CD ,_, 42_CD ±_NN 1_CD s_VBZ -_: 1_CD ,_, and_CC 82_CD ±_NN 5_CD s_VBZ -_: 1_CD for_IN the_DT cephalosporins_NNS ,_,
          nitrocefin_NN ,_, cefoxitin_NN ,_, cefaclor_NN ,_, and_CC cephalothin_NN ._. For_IN
          these_DT same_JJ substrates_NNS ,_, the_DT K_NNP 
          m_NN values_NNS were_VBD 4_CD ±_NN 1_CD μM_NN ,_, 1_CD ._. 1_CD ±_NN 0_CD ._. 1_CD μM_NN ,_,
          13_CD ±_NN 1_CD μM_NN ,_, and_CC 8_CD ._. 9_CD ±_NN 1_CD ._. 5_CD μM_NN ,_, respectively_RB ._. Two_CD
          penicillins_NNS were_VBD tested_VBN as_IN substrates_NNS ,_, and_CC penicillin_NN G_NNP
          and_CC ampicillin_NN exhibited_VBN K_NNP 
          m_NN values_NNS of_IN 38_CD ±_NN 12_CD μM_NN and_CC 55_CD ±_NN 5_CD μM_NN
          and_CC 
          k_NN 
          cat_NN values_NNS of_IN 600_CD ±_NN 100_CD s_VBZ -_: 1_CD and_CC 520_CD ±_NN
          10_CD s_VBZ -_: 1_CD ,_, respectively_RB (_( Table_NNP 4_LS )_) ._. Three_CD carbapenems_NNS were_VBD
          also_RB used_VBN as_IN substrates_NNS for_IN L_NNP 1_CD ,_, and_CC biapenem_NN ,_, imipenem_NN ,_,
          and_CC meropenem_NN exhibited_VBN K_NNP 
          m_NN values_NNS of_IN 32_CD ±_NN 1_CD μM_NN ,_, 57_CD ±_NN 7_CD μM_NN ,_, and_CC
          15_CD ±_NN 4_CD μM_NN and_CC 
          k_NN 
          cat_NN values_NNS of_IN 134_CD ±_NN 4_CD s_VBZ -_: 1_CD ,_, 370_CD ±_NN 5_CD s_VBZ
          -_: 1_CD ,_, and_CC 157_CD ±_NN 9_CD s_VBZ -_: 1_CD ,_, respectively_RB (_( Table_NNP 5_LS )_) ._. L_NNP 1_CD 's_POS
          preference_NN for_IN penicillins_NNS and_CC carbapenems_NNS over_IN
          cephalosporins_NNS ,_, as_IN exemplified_VBN by_IN the_DT 
          k_NN 
          cat_NN values_NNS ,_, is_VBZ in_IN agreement_NN with_IN
          previous_JJ studies_NNS and_CC supports_VBZ L_NNP 1_CD 's_POS placement_NN in_IN the_DT
          β-lactamase_JJ 3_CD c_SYM family_NN [_NN 9_CD ]_NN ._.
          Rapid-scanning_NNP visible_JJ spectra_NN of_IN 25_CD μM_NN wild-type_JJ L_NNP 1_CD
          with_IN 5_CD μM_NN nitrocefin_NN demonstrated_VBD a_DT decrease_NN in_IN
          absorbance_NN at_IN 390_CD nm_NN ,_, an_DT increase_NN at_IN 485_CD nm_NN ,_, and_CC a_DT rapid_JJ
          increase_NN and_CC slower_JJR decrease_NN in_IN absorbance_NN at_IN 665_CD nm_NN ._.
          These_DT spectra_NN are_VBP similar_JJ to_TO those_DT previously_RB reported_VBN
          for_IN wild-type_JJ L_NNP 1_CD and_CC nitrocefin_NN [_NN 39_CD ]_NN ,_, and_CC the_DT features_NNS
          can_MD be_VB attributed_VBN to_TO substrate_NN decay_NN ,_, product_NN formation_NN ,_,
          and_CC intermediate_JJ formation_NN and_CC decay_NN ,_, respectively_RB ._. Under_IN
          these_DT conditions_NNS ,_, 2_CD ._. 2_CD μM_NN intermediate_JJ was_VBD formed_VBN during_IN
          the_DT first_JJ 10_CD milliseconds_NNS of_IN the_DT reaction_NN (_( Figure_NN 2_LS )_) ,_, and_CC
          the_DT rate_NN of_IN decay_NN of_IN this_DT intermediate_JJ corresponds_NNS to_TO the_DT
          steady-state_JJ 
          k_NN 
          cat_NN (_( Table_NNP 3_LS )_) ._. To_TO probe_VB further_VB the_DT
          binding_JJ of_IN nitrocefin_NN to_TO wild-type_JJ L_NNP 1_CD ,_, stopped-flow_JJ
          fluorescence_NN studies_NNS were_VBD conducted_VBN as_RB previously_RB
          described_VBD [_NN 40_CD ]_NN (_( Figure_NN 3_LS )_) ._. The_DT reaction_NN of_IN wild-type_JJ L_NNP 1_CD
          with_IN nitrocefin_NN under_IN steady-state_JJ conditions_NNS at_IN 10_CD °_NN C_NNP
          resulted_VBD in_IN a_DT rapid_JJ decrease_NN in_IN fluorescence_NN followed_VBN by_IN
          a_DT rate-limiting_JJ return_NN of_IN fluorescence_NN (_( Figure_NN 3_CD A_DT )_) ._.
          Fitting_NNP of_IN the_DT data_NNS ,_, as_IN described_VBN by_IN Spencer_NNP 
          et_CC al_NN ._. [_NN 40_CD ]_NN ,_, resulted_VBD in_IN a_DT K_NNP 
          S_NNP value_NN for_IN wild-type_JJ L_NNP 1_CD of_IN 38_CD ±_NN 5_CD μM_NN
          (_( Figure_NN 3_CD B_NNP )_) ._.
        
        
          Ser_NNP 224_CD mutants_NNS
          (_( the_DT BBL_NNP numbering_VBG scheme_NN proposed_VBN in_IN reference_NN 41_CD was_VBD
          used_VBN throughout_IN this_DT manuscript_NN )_) ._. All_DT sequenced_JJ subclass_NNS
          Ba_NNP and_CC Bb_NNP metallo-β-lactamases_JJ (_( except_IN VIM-_NNP 1_LS )_) have_VBP a_DT
          lysine_NN residue_NN at_IN position_NN 224_CD [_NN 41_CD ]_NN ,_, and_CC all_DT
          computational_NN models_NNS for_IN substrate_NN binding_VBG to_TO the_DT
          metallo-β-lactamases_JJ assume_VB that_IN the_DT invariant_NN
          carboxylate_NN on_IN substrates_NNS forms_NNS an_DT electrostatic_JJ
          interaction_NN with_IN this_DT lysine_NN ._. In_IN L_NNP 1_CD ,_, the_DT residue_NN at_IN
          position_NN 224_CD is_VBZ a_DT serine_NN [_NN 35_CD ]_NN ,_, and_CC the_DT
          substrate-binding_JJ model_NN for_IN L_NNP 1_CD predicts_VBZ that_IN this_DT serine_NN
          residue_NN interacts_NNS with_IN the_DT carboxylate_NN on_IN substrate_NN via_IN a_DT
          water_NN molecule_NN [_NN 37_CD ]_NN ._. To_TO test_VB the_DT proposed_VBN role_NN of_IN
          Ser_NNP 224_CD in_IN L_NNP 1_CD ,_, serine_NN was_VBD changed_VBN to_TO an_DT alanine_NN (_( S_NNP 224_CD A_DT )_) ,_,
          aspartic_JJ acid_NN (_( S_NNP 224_CD D_NNP )_) ,_, and_CC lysine_NN (_( S_NNP 224_CD K_NNP )_) ,_, and_CC these_DT
          mutants_NNS were_VBD characterized_VBN using_VBG metal_NN analyses_NNS ,_, CD_NNP
          spectroscopy_NN ,_, steady-state_JJ kinetics_NNS ,_, and_CC pre-steady_JJ state_NN
          kinetic_JJ studies_NNS ._.
          Small-scale_NNP growth_NN cultures_NNS showed_VBD that_IN all_DT three_CD
          mutants_NNS were_VBD over-expressed_JJ at_IN levels_NNS comparable_JJ to_TO those_DT
          of_IN wild-type_JJ L_NNP 1_CD ._. Large-scale_NNP over-expression_JJ and_CC
          purification_NN of_IN the_DT mutants_NNS showed_VBD that_IN all_DT three_CD mutants_NNS
          were_VBD isolatable_JJ at_IN levels_NNS comparable_JJ to_TO those_DT of_IN
          wild-type_JJ L_NNP 1_CD ._. Metal_NN analyses_NNS of_IN the_DT S_NNP 224_CD A_DT and_CC S_NNP 224_CD D_NNP
          mutants_NNS showed_VBD that_IN both_DT mutants_NNS bind_NN nearly_RB two_CD Zn_NNP (_( II_NNP )_)
          ions_NNS (_( Table_NNP 2_LS )_) ,_, like_IN wild-type_JJ L_NNP 1_CD [_NN 36_CD ]_NN ;_: however_RB ,_, the_DT
          S_NNP 224_CD K_NNP mutant_JJ binds_NNS only_RB 1_CD ._. 0_CD Zn_NNP (_( II_NNP )_) per_IN protein_NN ._. CD_NN
          spectra_NN of_IN the_DT mutants_NNS were_VBD similar_JJ to_TO those_DT of_IN wild-type_JJ
          L_NNP 1_CD (_( see_VB Figure_NN in_IN Additional_JJ materials_NNS )_) ._. Steady-state_NNP
          kinetic_JJ studies_NNS were_VBD conducted_VBN with_IN all_DT three_CD mutants_NNS in_IN
          buffer_NN containing_VBG 100_CD μM_NN ZnCl_NNP 
          2_CD to_TO ensure_VB that_IN both_DT Zn_NNP (_( II_NNP )_) binding_JJ
          sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._. Addition_NNP of_IN higher_JJR
          concentrations_NNS of_IN Zn_NNP (_( II_NNP )_) did_VBD not_RB result_VB in_IN different_JJ
          values_NNS for_IN the_DT steady-state_JJ kinetic_JJ constants_NNS in_IN Tables_NNP
          3_CD ,_, 4_CD ,_, 5_CD ._.
          When_WRB the_DT cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT
          S_NNP 224_CD A_DT and_CC S_NNP 224_CD K_NNP mutants_NNS exhibited_VBN 2_CD -_: to_TO 4_CD -_: fold_VB changes_NNS in_IN
          K_NNP 
          m_NN values_NNS (_( Table_NNP 3_LS )_) ._. In_IN studies_NNS with_IN
          cefoxitin_NN ,_, cefaclor_NN ,_, and_CC cephalothin_NN as_IN substrate_NN ,_, the_DT
          observed_VBN 
          k_NN 
          cat_NN values_NNS for_IN the_DT S_NNP 224_CD A_DT and_CC S_NNP 224_CD K_NNP
          mutants_NNS were_VBD 2_CD -_: to_TO 7_CD -_: fold_VB lower_JJR ;_: however_RB ,_, the_DT 
          k_NN 
          cat_NN values_NNS when_WRB using_VBG nitrocefin_NN as_IN
          substrate_NN were_VBD slightly_RB higher_JJR (_( <_NN 2_CD -_: fold_VB )_) ._. On_IN the_DT
          other_JJ hand_NN ,_, the_DT S_NNP 224_CD D_NNP mutant_JJ exhibited_VBN 3_CD -_: to_TO 50_CD -_: fold_VB
          higher_JJR K_NNP 
          m_NN values_NNS and_CC 2_CD -_: to_TO 20_CD -_: fold_VB lower_JJR 
          k_NN 
          cat_NN values_NNS for_IN the_DT cephalosporins_NNS
          tested_VBN ._. A_DT similar_JJ trend_NN was_VBD observed_VBN in_IN kinetic_JJ studies_NNS
          when_WRB using_VBG penicillins_NNS as_IN substrates_NNS (_( Table_NNP 4_LS )_) ._.
          Generally_RB ,_, the_DT S_NNP 224_CD A_DT and_CC S_NNP 224_CD K_NNP mutants_NNS exhibited_VBN small_JJ
          changes_NNS in_IN K_NNP 
          m_NN and_CC 
          k_NN 
          cat_NN ,_, while_IN the_DT S_NNP 224_CD D_NNP mutant_JJ yielded_VBD
          20_CD -_: to_TO 40_CD -_: fold_VB increased_VBN values_NNS for_IN K_NNP 
          m_NN and_CC >_NN 10_CD -_: fold_VB decreases_NNS in_IN 
          k_NN 
          cat_NN when_WRB using_VBG the_DT penicillins_NNS as_IN
          substrates_NNS ._. When_WRB the_DT carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS
          however_RB ,_, the_DT changes_NNS in_IN K_NNP 
          m_NN values_NNS were_VBD relatively_RB smaller_JJR than_IN
          with_IN the_DT other_JJ substrates_NNS ,_, and_CC 2_CD -_: to_TO 37_CD -_: fold_VB changes_NNS in_IN 
          k_NN 
          cat_NN were_VBD observed_VBN (_( Table_NNP 5_LS )_) ._.
          Rapid-scanning_NNP Vis_NNP studies_NNS of_IN the_DT S_NNP 224_CD X_NNP mutants_NNS were_VBD
          conducted_VBN to_TO probe_VB whether_IN the_DT mutations_NNS caused_VBD changes_NNS
          in_IN the_DT amount_NN of_IN intermediate_JJ that_IN accumulates_NNS during_IN
          catalysis_NNS ._. When_WRB 50_CD μM_NN S_NNP 224_CD A_DT was_VBD reacted_VBN with_IN 5_CD μM_NN
          nitrocefin_NN ,_, 1_CD ._. 7_CD μM_NN intermediate_JJ formed_VBN during_IN the_DT first_JJ
          10_CD milliseconds_NNS of_IN the_DT reaction_NN (_( Figure_NN 2_LS )_) ,_, and_CC rate_NN of_IN
          decay_NN of_IN this_DT intermediate_JJ was_VBD equal_JJ to_TO the_DT steady-state_JJ 
          k_NN 
          cat_NN (_( Table_NNP 3_LS )_) ._. In_IN spite_NN of_IN utilizing_VBG a_DT
          number_NN of_IN reaction_NN conditions_NNS ,_, the_DT S_NNP 224_CD K_NNP and_CC S_NNP 224_CD D_NNP
          mutants_NNS yielded_VBD rapid-scan_JJ spectra_NN with_IN no_DT detectable_JJ
          absorbances_NNS at_IN 665_CD nm_NN (_( Figure_NN 2_LS )_) ,_, indicating_VBG that_IN the_DT
          intermediate_JJ is_VBZ not_RB stabilized_VBN as_RB well_RB in_IN these_DT mutants_NNS
          as_IN in_IN wild-type_JJ L_NNP 1_CD ._. Stopped-flow_NNP fluorescence_NN studies_NNS at_IN
          10_CD °_NN C_NNP with_IN the_DT S_NNP 224_CD A_DT ,_, S_NNP 224_CD D_NNP ,_, and_CC S_NNP 224_CD K_NNP mutants_NNS and_CC
          nitrocefin_NN as_IN the_DT substrate_NN resulted_VBD in_IN K_NNP 
          S_NNP values_NNS of_IN 39_CD ±_NN 10_CD ,_, 213_CD ±_NN 63_CD ,_, and_CC 33_CD
          ±_NN 5_CD μM_NN ,_, respectively_RB ._.
        
        
          Asn_NNP 233_CD mutants_NNS
          Two-thirds_NNS of_IN all_DT sequenced_JJ metallo-β-lactamases_JJ have_VBP
          an_DT Asn_NNP at_IN position_NN 233_CD [_NN 41_CD ]_NN ,_, and_CC this_DT residue_NN was_VBD
          predicted_VBN [_NN 42_CD ]_NN and_CC shown_VBN [_NN 43_CD ]_NN to_TO be_VB involved_VBN with_IN
          substrate_NN binding_JJ and_CC activation_NN by_IN interacting_VBG
          electrostatically_RB with_IN the_DT substrate_NN β-lactam_JJ carbonyl_NN ._.
          However_RB ,_, in_IN L_NNP 1_CD ,_, Asn_NNP 233_CD is_VBZ 14_CD Å_NN away_RB from_IN the_DT modeled_VBN
          position_NN of_IN the_DT substrate_NN β-lactam_JJ carbonyl_NN [_NN 37_CD ]_NN ._. To_TO
          test_VB the_DT role_NN of_IN Asn_NNP 233_CD in_IN substrate_NN binding_VBG ,_, the_DT Asn_NNP was_VBD
          changed_VBN to_TO a_DT leucine_NN (_( N_NNP 233_CD L_NNP )_) and_CC to_TO an_DT aspartic_JJ acid_NN
          (_( N_NNP 233_CD D_NNP )_) ,_, and_CC these_DT mutants_NNS were_VBD characterized_VBN by_IN using_VBG
          metal_NN analyses_NNS ,_, CD_NNP spectroscopy_NN ,_, steady-state_JJ kinetics_NNS ,_,
          and_CC pre-steady_JJ state_NN kinetic_JJ studies_NNS ._.
          Small-scale_NNP growth_NN cultures_NNS showed_VBD that_IN both_DT mutants_NNS
          were_VBD over-expressed_JJ at_IN levels_NNS comparable_JJ to_TO that_DT of_IN
          wild-type_JJ L_NNP 1_CD ._. Large-scale_NNP over-expression_JJ and_CC
          purification_NN of_IN the_DT mutants_NNS showed_VBD that_IN both_DT mutants_NNS were_VBD
          isolatable_JJ at_IN levels_NNS comparable_JJ to_TO that_DT of_IN wild-type_JJ L_NNP 1_CD ._.
          Metal_NN analyses_NNS of_IN the_DT N_NNP 233_CD L_NNP and_CC N_NNP 233_CD D_NNP mutants_NNS showed_VBD that_IN
          both_DT bind_NN nearly_RB two_CD Zn_NNP (_( II_NNP )_) ions_NNS (_( Table_NNP 2_LS )_) ,_, like_IN
          wild-type_JJ L_NNP 1_CD [_NN 36_CD ]_NN ._. CD_NNP spectra_NN of_IN the_DT mutants_NNS were_VBD
          similar_JJ to_TO those_DT of_IN wild-type_JJ L_NNP 1_CD ._. Steady-state_NNP kinetic_JJ
          studies_NNS were_VBD conducted_VBN with_IN both_DT mutants_NNS in_IN buffer_NN
          containing_VBG 100_CD μM_NN ZnCl_NNP 
          2_CD to_TO ensure_VB that_IN both_DT Zn_NNP (_( II_NNP )_) binding_JJ
          sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._. Addition_NNP of_IN higher_JJR
          concentrations_NNS of_IN Zn_NNP (_( II_NNP )_) did_VBD not_RB result_VB in_IN different_JJ
          values_NNS for_IN the_DT steady-state_JJ kinetic_JJ constants_NNS in_IN Tables_NNP
          3_CD ,_, 4_CD ,_, 5_CD ._.
          With_IN all_DT substrates_NNS tested_VBN ,_, the_DT N_NNP 233_CD L_NNP and_CC N_NNP 233_CD D_NNP
          mutants_NNS exhibited_VBN K_NNP 
          m_NN values_NNS that_WDT differed_VBD less_JJR than_IN a_DT
          factor_NN of_IN 4_CD than_IN that_DT observed_VBD for_IN wild-type_JJ L_NNP 1_CD (_( Tables_NNP
          3_CD ,_, 4_CD ,_, 5_LS )_) ._. The_DT 
          k_NN 
          cat_NN values_NNS exhibited_VBN by_IN these_DT mutants_NNS
          for_IN all_DT substrates_NNS also_RB differed_VBD by_IN less_JJR than_IN a_DT factor_NN of_IN
          4_CD ,_, except_IN when_WRB biapenem_NN and_CC meropenem_NN were_VBD used_VBN as_IN
          substrates_NNS for_IN the_DT N_NNP 233_CD D_NNP mutant_JJ ._. With_IN these_DT two_CD
          substrates_NNS ,_, there_EX was_VBD a_DT 19_CD -_: fold_VB and_CC 45_CD -_: fold_VB decrease_VB in_IN
          the_DT 
          k_NN 
          cat_NN values_NNS when_WRB using_VBG biapenem_NN and_CC
          meropenem_NN ,_, respectively_RB (_( Table_NNP 5_LS )_) ._. The_DT steady-state_JJ
          kinetic_JJ data_NNS generally_RB support_VBP the_DT prediction_NN that_IN Asn_NNP 233_CD
          does_VBZ not_RB play_VB a_DT large_JJ role_NN in_IN binding_JJ or_CC catalysis_NNS ._.
          However_RB ,_, rapid-scanning_JJ Vis_NNP studies_NNS of_IN N_NNP 233_CD L_NNP and_CC N_NNP 233_CD D_NNP
          with_IN nitrocefin_NN demonstrate_VB that_IN no_DT detectable_JJ amounts_NNS of_IN
          intermediate_JJ are_VBP formed_VBN during_IN the_DT reaction_NN ,_, even_RB when_WRB
          using_VBG a_DT wide_JJ number_NN of_IN reaction_NN conditions_NNS (_( Figure_NN 2_LS )_) ._.
          Stopped-flow_NNP fluorescence_NN studies_NNS at_IN 10_CD °_NN C_NNP with_IN the_DT N_NNP 233_CD L_NNP
          and_CC N_NNP 233_CD D_NNP mutants_NNS and_CC nitrocefin_NN as_IN substrate_NN resulted_VBD in_IN
          K_NNP 
          S_NNP values_NNS of_IN 26_CD ±_NN 9_CD and_CC 25_CD ±_NN 8_CD μM_NN ,_,
          respectively_RB ._.
        
        
          Tyr_NNP 228_CD mutants_NNS
          The_DT substrate-binding_JJ model_NN showed_VBD that_IN Tyr_NNP 228_CD in_IN L_NNP 1_CD
          was_VBD position-conserved_JJ with_IN Asn_NNP 233_CD in_IN the_DT other_JJ
          crystallographically_RB characterized_VBN metallo-β-lactamases_JJ [_NN
          37_CD 42_CD 44_CD 45_CD 46_CD ]_NN ._. Spencer_NNP and_CC coworkers_NNS postulated_JJ that_IN
          Tyr_NNP 228_CD is_VBZ part_NN of_IN an_DT oxyanion_NN hole_NN that_IN interacts_NNS with_IN
          the_DT β-lactam_JJ carbonyl_NN on_IN substrate_NN and_CC helps_VBZ to_TO stabilize_VB
          the_DT putative_JJ tetrahedral_NN intermediate_JJ formed_VBN during_IN
          substrate_NN turnover_NN [_NN 37_CD ]_NN ._. To_TO test_VB this_DT hypothesis_NNS ,_,
          Tyr_NNP 228_CD was_VBD changed_VBN to_TO an_DT alanine_NN and_CC to_TO a_DT phenylalanine_NN
          to_TO afford_VB the_DT Y_NNP 228_CD A_DT and_CC Y_NNP 228_CD F_NN mutants_NNS ,_, respectively_RB ._.
          Small-scale_NNP growth_NN cultures_NNS showed_VBD that_IN both_DT mutants_NNS
          were_VBD over-expressed_JJ at_IN levels_NNS comparable_JJ to_TO those_DT of_IN
          wild-type_JJ L_NNP 1_CD ._. Large-scale_NNP over-expression_JJ and_CC
          purification_NN of_IN the_DT Y_NNP 228_CD A_DT and_CC Y_NNP 228_CD F_NN mutants_NNS showed_VBD that_IN
          both_DT mutants_NNS were_VBD isolatable_JJ at_IN levels_NNS comparable_JJ to_TO
          those_DT of_IN wild-type_JJ L_NNP 1_CD ._. Metal_NN analyses_NNS of_IN the_DT mutants_NNS
          showed_VBD that_IN both_DT bind_NN nearly_RB two_CD Zn_NNP (_( II_NNP )_) ions_NNS (_( Table_NNP 2_LS )_) ,_,
          like_IN wild-type_JJ L_NNP 1_CD [_NN 36_CD ]_NN ,_, and_CC CD_NNP spectra_NN of_IN the_DT mutants_NNS
          were_VBD similar_JJ to_TO those_DT of_IN wild-type_JJ L_NNP 1_CD ._. Steady-state_NNP
          kinetic_JJ studies_NNS were_VBD conducted_VBN with_IN both_DT mutants_NNS in_IN
          buffer_NN containing_VBG 100_CD μM_NN ZnCl_NNP 
          2_CD to_TO ensure_VB that_IN both_DT Zn_NNP (_( II_NNP )_) binding_JJ
          sites_NNS were_VBD saturated_VBN in_IN these_DT studies_NNS ._. Addition_NNP of_IN higher_JJR
          concentrations_NNS of_IN Zn_NNP (_( II_NNP )_) did_VBD not_RB result_VB in_IN different_JJ
          values_NNS for_IN the_DT steady-state_JJ kinetic_JJ constants_NNS in_IN Tables_NNP
          3_CD ,_, 4_CD ,_, 5_CD ._.
          When_WRB cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT Y_NNP 228_CD A_DT
          and_CC Y_NNP 228_CD F_NN mutants_NNS exhibited_VBN K_NNP 
          m_NN values_NNS that_WDT were_VBD 6_CD -_: to_TO 45_CD -_: fold_VB
          higher_JJR than_IN those_DT observed_VBN for_IN wild-type_JJ L_NNP 1_CD (_( Table_NNP 3_LS )_) ._.
          The_DT largest_JJS change_NN in_IN K_NNP 
          m_NN was_VBD observed_VBN when_WRB cefaclor_NN was_VBD used_VBN
          as_IN substrate_NN ,_, and_CC the_DT smallest_JJS change_NN was_VBD observed_VBN when_WRB
          nitrocefin_NN was_VBD used_VBN as_IN substrate_NN ._. The_DT Tyr_NNP 228_CD mutants_NNS
          exhibited_VBN <_NN 4_CD -_: fold_VB change_NN in_IN 
          k_NN 
          cat_NN values_NNS for_IN the_DT cephalosporins_NNS
          tested_VBN (_( Table_NNP 3_LS )_) ,_, suggesting_VBG that_IN Tyr_NNP 228_CD is_VBZ not_RB playing_VBG a_DT
          large_JJ role_NN in_IN catalysis_NNS ._. When_WRB penicillins_NNS were_VBD used_VBN as_IN
          substrates_NNS ,_, the_DT Tyr_NNP 228_CD mutants_NNS exhibited_VBN 3_CD -_: to_TO 13_CD -_: fold_VB
          increased_VBN K_NNP 
          m_NN values_NNS and_CC <_NN 2_CD -_: fold_VB changes_NNS in_IN 
          k_NN 
          cat_NN ,_, as_IN compared_VBN to_TO the_DT values_NNS
          ascertained_JJ using_VBG wild-type_JJ L_NNP 1_CD (_( Table_NNP 4_LS )_) ._. On_IN the_DT other_JJ
          hand_NN when_WRB carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS ,_, the_DT Tyr_NNP 228_CD
          mutants_NNS exhibited_VBN <_NN 6_CD -_: fold_VB increases_NNS in_IN K_NNP 
          m_NN values_NNS as_IN compared_VBN to_TO those_DT values_NNS
          for_IN wild-type_JJ L_NNP 1_CD (_( Table_NNP 5_LS )_) ._. Interestingly_RB ,_, there_EX was_VBD a_DT 2_CD -_:
          to_TO 8_CD -_: fold_VB drop_NN in_IN 
          k_NN 
          cat_NN values_NNS for_IN the_DT Tyr_NNP 228_CD mutants_NNS ,_, as_IN
          compared_VBN to_TO values_NNS observed_VBD for_IN wild-type_JJ L_NNP 1_CD ,_, when_WRB using_VBG
          the_DT carbapenems_NNS as_IN substrates_NNS ._.
          Rapid-scanning_NNP Vis_NNP spectra_NN of_IN the_DT reaction_NN of_IN the_DT
          Y_NNP 228_CD A_DT and_CC Y_NNP 228_CD F_NN mutants_NNS with_IN nitrocefin_NN demonstrated_VBD a_DT
          marked_VBD decrease_NN in_IN the_DT amount_NN of_IN intermediate_JJ formed_VBN with_IN
          these_DT mutants_NNS (_( Figure_NN 2_LS )_) ._. In_IN reactions_NNS with_IN 50_CD μM_NN mutant_JJ
          and_CC 5_CD μM_NN nitrocefin_NN ,_, only_RB 0_CD ._. 75_CD and_CC <_NN 0_CD ._. 30_CD μM_NN
          intermediate_JJ formed_VBN for_IN the_DT Y_NNP 228_CD F_NN and_CC Y_NNP 228_CD A_DT mutants_NNS ,_,
          respectively_RB ._. The_DT concentration_NN of_IN mutants_NNS were_VBD varied_VBN
          between_IN 25_CD to_TO 150_CD μM_NN to_TO ensure_VB that_IN all_DT of_IN the_DT substrate_NN
          was_VBD bound_VBN ;_: however_RB ,_, none_NN of_IN the_DT reactions_NNS resulted_VBD in_IN the_DT
          detection_NN of_IN intermediate_JJ at_IN levels_NNS observed_VBD for_IN
          wild-type_JJ L_NNP 1_CD (_( data_NNS not_RB shown_VBN )_) ._. Stopped-flow_NNP fluorescence_NN
          studies_NNS at_IN 10_CD °_NN C_NNP of_IN nitrocefin_NN hydrolysis_NNS by_IN Y_NNP 191_CD A_DT and_CC
          Y_NNP 191_CD F_NN resulted_VBD in_IN K_NNP 
          S_NNP values_NNS of_IN 85_CD ±_NN 9_CD and_CC 22_CD ±_NN 6_CD μM_NN ,_,
          respectively_RB ._.
        
        
          Ile_NNP 164_CD and_CC Phe_NNP 158_CD mutants_NNS
          All_DT crystallographically_RB characterized_VBN
          metallo-β-lactamases_JJ have_VBP a_DT flexible_JJ amino_JJ acid_NN chain_NN
          that_WDT extends_VBZ over_IN the_DT active_JJ site_NN [_NN 37_CD 42_CD 44_CD 45_CD 46_CD 47_CD 48_CD
          49_CD ]_NN ._. Previous_JJ NMR_NNP studies_NNS on_IN CcrA_NNP have_VBP shown_VBN that_IN this_DT
          loop_NN "_'' clamps_NNS down_RB "_'' on_IN substrate_NN or_CC inhibitor_NN upon_IN
          binding_JJ ,_, and_CC there_EX is_VBZ speculation_NN that_IN the_DT distortion_NN of_IN
          substrate_NN upon_IN clamping_VBG down_RB of_IN the_DT loop_NN may_MD drive_VB
          catalysis_NNS [_NN 50_CD ]_NN ._. The_DT crystal_NN structure_NN of_IN L_NNP 1_CD showed_VBD
          that_IN there_EX is_VBZ a_DT large_JJ loop_NN that_WDT extends_VBZ over_IN the_DT active_JJ
          site_NN ,_, and_CC modeling_NN studies_NNS have_VBP predicted_VBN that_IN two_CD
          residues_NNS ,_, Ile_NNP 164_CD and_CC Phe_NNP 158_CD ,_, make_VBP significant_JJ contacts_NNS
          with_IN large_JJ ,_, hydrophobic_JJ substituents_NNS at_IN the_DT 2_CD '_POS or_CC 6_CD '_POS
          positions_NNS on_IN penicillins_NNS ,_, cephalosporins_NNS ,_, or_CC carbapenems_NNS
          [_NN 37_CD ]_NN ._. To_TO test_VB this_DT prediction_NN ,_, Ile_NNP 164_CD and_CC Phe_NNP 158_CD were_VBD
          changed_VBN from_IN large_JJ ,_, hydrophobic_JJ residues_NNS to_TO alanines_NNS to_TO
          afford_VB the_DT I_PRP 164_CD A_DT and_CC F_NN 158_CD A_DT mutants_NNS ._.
          Small-scale_NNP growth_NN cultures_NNS demonstrated_VBD the_DT I_PRP 164_CD A_DT and_CC
          F_NN 158_CD A_DT mutants_NNS were_VBD over-expressed_JJ at_IN levels_NNS comparable_JJ to_TO
          that_DT of_IN wild-type_JJ L_NNP 1_CD (_( data_NNS not_RB shown_VBN )_) ._. Large-scale_NNP
          over-expression_JJ and_CC purification_NN of_IN the_DT mutants_NNS resulted_VBD
          in_IN comparable_JJ quantities_NNS of_IN isolatable_JJ enzymes_NNS ,_, which_WDT had_VBD
          identical_JJ CD_NNP spectra_NN as_IN wild-type_JJ L_NNP 1_CD and_CC bound_VBN slightly_RB
          less_JJR Zn_NNP (_( II_NNP )_) than_IN wild-type_JJ L_NNP 1_CD (_( Table_NNP 2_LS )_) ._. All_DT steady-state_JJ
          kinetic_JJ studies_NNS were_VBD conducted_VBN in_IN buffers_NNS containing_VBG 100_CD
          μM_NN ZnCl_NNP 
          2_CD to_TO ensure_VB that_IN both_DT metal_NN binding_JJ
          sites_NNS were_VBD saturated_VBN during_IN the_DT studies_NNS ._.
          When_WRB using_VBG the_DT cephalosporins_NNS ,_, nitrocefin_NN ,_, cefoxitin_NN ,_,
          and_CC cephalothin_NN ,_, as_IN substrates_NNS and_CC the_DT I_PRP 164_CD A_DT mutant_JJ ,_,
          there_EX were_VBD 2_CD -_: to_TO 10_CD -_: fold_VB (_( only_RB for_IN cefoxitin_NN )_) increases_NNS
          in_IN K_NNP 
          m_NN and_CC 2_CD -_: to_TO 4_CD -_: fold_VB increases_NNS in_IN 
          k_NN 
          cat_NN observed_VBD (_( Table_NNP 3_LS )_) ._. However_RB when_WRB
          cefaclor_NN was_VBD used_VBN as_IN substrate_NN ,_, the_DT I_PRP 164_CD A_DT mutant_JJ
          exhibited_VBN a_DT 3_CD -_: fold_VB decrease_VB in_IN K_NNP 
          m_NN and_CC a_DT 1_CD ._. 5_CD -_: fold_VB decrease_VB in_IN 
          k_NN 
          cat_NN (_( Table_NNP 3_LS )_) ._. On_IN the_DT other_JJ hand_NN ,_, the_DT
          K_NNP 
          m_NN and_CC 
          k_NN 
          cat_NN values_NNS for_IN the_DT I_PRP 164_CD A_DT mutant_JJ when_WRB
          the_DT penicillins_NNS or_CC carbapenems_NNS were_VBD used_VBN as_IN substrates_NNS
          were_VBD very_RB similar_JJ to_TO those_DT numbers_NNS exhibited_VBN by_IN wild-type_JJ
          L_NNP 1_CD (_( Tables_NNP 4_CD and_CC 5_LS )_) ._.
          When_WRB the_DT cephalosporins_NNS were_VBD used_VBN as_IN substrates_NNS for_IN
          the_DT F_NN 158_CD A_DT mutant_JJ ,_, the_DT K_NNP 
          m_NN values_NNS observed_VBD were_VBD 7_CD -_: to_TO 31_CD -_: fold_VB
          higher_JJR than_IN those_DT determined_VBN for_IN wild-type_JJ L_NNP 1_CD ,_, and_CC
          surprisingly_RB ,_, the_DT 
          k_NN 
          cat_NN values_NNS were_VBD 2_CD -_: to_TO 31_CD -_: fold_VB higher_JJR
          than_IN those_DT exhibited_VBN by_IN wild-type_JJ L_NNP 1_CD (_( Table_NNP 3_LS )_) ._. As_IN with_IN
          the_DT I_PRP 164_CD A_DT mutant_JJ ,_, the_DT changes_NNS in_IN K_NNP 
          m_NN and_CC 
          k_NN 
          cat_NN for_IN the_DT penicillins_NNS and_CC
          carbapenems_NNS were_VBD relatively_RB small_JJ ,_, as_IN compared_VBN with_IN the_DT
          values_NNS obtained_VBN with_IN the_DT cephalosporins_NNS (_( Table_NNP 4_LS )_) ._.
          Rapid-scanning_NNP Vis_NNP studies_NNS on_IN nitrocefin_NN hydrolysis_NNS by_IN
          I_PRP 164_CD A_DT and_CC F_NN 158_CD A_DT showed_VBD a_DT marked_VBD decrease_NN in_IN intermediate_JJ
          accumulation_NN ,_, with_IN the_DT I_PRP 164_CD A_DT mutant_JJ generating_NN <_NN 0_CD ._. 30_CD
          μM_NN intermediate_JJ and_CC the_DT F_NN 158_CD A_DT producing_VBG no_DT detectable_JJ
          intermediate_JJ (_( Figure_NN 2_LS )_) ._. Stopped-flow_NNP fluorescence_NN
          studies_NNS at_IN 10_CD °_NN C_NNP resulted_VBD in_IN a_DT K_NNP 
          S_NNP value_NN of_IN 31_CD ±_NN 11_CD μM_NN for_IN the_DT I_PRP 164_CD A_DT
          mutant_JJ ._. The_DT reaction_NN of_IN F_NN 158_CD A_DT with_IN nitrocefin_NN was_VBD so_RB
          rapid_JJ ,_, we_PRP could_MD not_RB determine_VB a_DT K_NNP 
          S_NNP value_NN for_IN this_DT mutant_JJ ._.
        
      
      
        Discussion_NNP
        β-_NN Lactam_NNP containing_VBG antibiotics_NNS constitute_VBP the_DT largest_JJS
        class_NN of_IN antibiotics_NNS ,_, and_CC these_DT compounds_NNS are_VBP relatively_RB
        inexpensive_JJ to_TO produce_VB ,_, cause_VB minor_JJ side_NN effects_NNS ,_, and_CC are_VBP
        effective_JJ towards_IN a_DT number_NN of_IN bacterial_JJ strains_NNS ._.
        Nonetheless_RB ,_, bacterial_JJ resistance_NN to_TO these_DT antibiotics_NNS is_VBZ
        extensive_JJ ,_, most_RBS commonly_RB due_JJ to_TO the_DT bacterial_JJ production_NN of_IN
        β-lactamases_JJ [_NN 10_CD 51_CD ]_NN ._. In_IN fact_NN ,_, there_EX have_VBP been_VBN over_IN 300_CD
        distinct_JJ β-lactamases_JJ reported_VBN ,_, and_CC most_JJS of_IN these_DT enzymes_NNS
        utilize_VB an_DT active_JJ site_NN serine_NN group_NN to_TO nucleophilically_RB
        attack_VB the_DT β-lactam_JJ carbonyl_NN ,_, resulting_VBG in_IN a_DT hydrolyzed_JJ
        product_NN that_WDT is_VBZ covalently_RB attached_VBN to_TO the_DT active_JJ site_NN ._. To_TO
        combat_VB these_DT enzymes_NNS ,_, β-lactamase_JJ inhibitors_NNS such_JJ as_IN
        clavulanic_JJ acid_NN ,_, sulbactam_NN ,_, and_CC tazobactam_NN have_VBP been_VBN given_VBN
        in_IN combination_NN with_IN a_DT β-lactam_JJ containing_VBG antibiotic_JJ to_TO
        treat_VB bacterial_JJ infections_NNS [_NN 52_CD ]_NN ._. One_CD class_NN of_IN
        β-lactamases_JJ that_WDT are_VBP particularly_RB unaffected_JJ by_IN the_DT known_VBN
        β-lactamase_JJ inhibitors_NNS and_CC have_VBP been_VBN shown_VBN to_TO hydrolyze_NN
        almost_RB all_DT known_VBN β-lactam_JJ containing_VBG antibiotics_NNS including_VBG
        late_JJ generation_NN carbapenems_NNS at_IN high_JJ rates_NNS are_VBP the_DT
        metallo-β-lactamases_JJ [_NN 14_CD 15_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._. Although_IN there_EX
        are_VBP no_DT reports_NNS of_IN metallo-β-lactamases_JJ isolated_VBN from_IN major_JJ
        pathogens_NNS [_NN 51_CD 53_CD ]_NN ,_, these_DT enzymes_NNS are_VBP produced_VBN by_IN
        pathogens_NNS such_JJ as_IN 
        B_NNP ._. fragilis_NNS ,_, S_NNP ._. maltophilia_NN ,_, and_CC 
        P_NN ._. aeruginosa_NN ._. It_PRP is_VBZ inevitable_JJ that_IN
        the_DT continued_VBN and_CC extensive_JJ use_NN of_IN β-lactam_JJ antibiotics_NNS
        will_MD result_VB in_IN a_DT major_JJ pathogen_NN that_WDT produces_VBZ a_DT
        metallo-β-lactamase_JJ ._.
        Efforts_NNS to_TO solve_VB the_DT crystal_NN structure_NN of_IN one_CD of_IN the_DT
        metallo-β-lactamases_JJ with_IN a_DT bound_VBN substrate_NN molecule_NN have_VBP
        failed_VBN ,_, most_RBS likely_JJ due_NN to_TO the_DT high_JJ activity_NN of_IN the_DT enzymes_NNS
        towards_IN all_DT β-lactam_JJ containing_VBG antibiotics_NNS [_NN 37_CD 54_CD ]_NN ._.
        Therefore_RB ,_, computational_NN studies_NNS have_VBP been_VBN used_VBN extensively_RB
        to_TO study_VB substrate_NN binding_VBG ,_, the_DT role_NN of_IN the_DT Zn_NNP (_( II_NNP )_) ions_NNS in_IN
        catalysis_NNS ,_, the_DT protonation_NN state_NN of_IN the_DT active_JJ site_NN ,_, and_CC
        inhibitor_NN binding_JJ [_NN 37_CD 42_CD 55_CD 56_CD 57_CD 58_CD 59_CD ]_NN ._. All_DT of_IN the_DT
        substrate_NN binding_JJ models_NNS have_VBP made_VBN assumptions_NNS before_IN the_DT
        substrate_NN was_VBD docked_JJ into_IN the_DT active_JJ site_NN [_NN 37_CD 42_CD ]_NN ,_, and_CC
        some_DT of_IN these_DT assumptions_NNS have_VBP been_VBN shown_VBN to_TO be_VB invalid_JJ for_IN
        certain_JJ substrates_NNS [_NN 43_CD ]_NN ._. With_IN L_NNP 1_CD ,_, two_CD key_JJ assumptions_NNS
        were_VBD made_VBN :_: (_( 1_LS )_) the_DT bridging_VBG hydroxide_NN functions_NNS as_IN the_DT
        nucleophile_NN during_IN catalysis_NNS and_CC (_( 2_LS )_) Zn_NNP 
        1_CD coordinates_VBZ the_DT β-lactam_JJ carbonyl_NN [_NN 37_CD
        ]_NN ._. With_IN these_DT assumptions_NNS and_CC after_IN energy_NN minimizations_NNS ,_,
        Ser_NNP 224_CD was_VBD predicted_VBN to_TO hydrogen_NN bond_NN to_TO the_DT substrate_NN
        carboxylate_NN [_NN 37_CD ]_NN ,_, reminiscent_NN of_IN the_DT role_NN predicted_VBD for_IN
        Lys_NNP 224_CD in_IN CcrA_NNP [_NN 42_CD ]_NN ._. Ullah_NNP 
        et_CC al_NN ._. predicted_VBD that_IN Phe_NNP 158_CD and_CC Ile_NNP
        164_CD form_NN hydrophobic_JJ interactions_NNS with_IN bulky_JJ substituents_NNS
        on_IN the_DT substrate_NN ,_, suggesting_VBG that_IN the_DT loss_NN of_IN these_DT
        residues_NNS would_MD only_RB affect_VB binding_JJ of_IN substrates_NNS with_IN large_JJ
        aromatic_JJ substituents_NNS [_NN 37_CD ]_NN ._. In_IN the_DT modeling_NN studies_NNS on_IN
        CcrA_NNP [_NN 42_CD ]_NN ,_, Asn_NNP 233_CD was_VBD predicted_VBN to_TO interact_NN with_IN the_DT
        β-lactam_JJ carbonyl_NN on_IN substrate_NN ,_, and_CC mutagenesis_NNS studies_NNS
        have_VBP supported_VBN this_DT prediction_NN [_NN 43_CD ]_NN ._. Although_IN Asn_NNP 233_CD is_VBZ
        sequence_NN conserved_JJ in_IN L_NNP 1_CD [_NN 35_CD ]_NN ,_, it_PRP is_VBZ located_VBN 14_CD Å_NN away_RB
        from_IN the_DT modeled_VBN position_NN of_IN the_DT β-lactam_JJ carbonyl_NN and_CC was_VBD
        predicted_VBN not_RB to_TO play_VB a_DT role_NN in_IN substrate_NN binding_JJ to_TO L_NNP 1_CD [_NN
        37_CD ]_NN ._. On_IN the_DT other_JJ hand_NN ,_, the_DT substrate-binding_JJ model_NN
        predicted_VBD that_IN Tyr_NNP 228_CD was_VBD in_IN position_NN to_TO offer_VB a_DT hydrogen_NN
        bond_NN to_TO the_DT β-lactam_JJ carbonyl_NN and_CC participate_VB in_IN an_DT
        oxyanion_NN hole_NN that_WDT was_VBD proposed_VBN to_TO form_VB as_IN the_DT substrate_NN
        was_VBD hydrolyzed_JJ [_NN 37_CD ]_NN ._. By_IN using_VBG the_DT crystal_NN structure_NN and_CC
        modeling_NN studies_NNS on_IN L_NNP 1_CD ,_, Ullah_NNP 
        et_CC al_NN ._. proposed_VBD a_DT reaction_NN mechanism_NN
        for_IN the_DT enzyme_NN [_NN 37_CD ]_NN ._. To_TO test_VB this_DT proposed_JJ mechanism_NN and_CC
        the_DT proposed_VBN roles_NNS of_IN the_DT amino_JJ acids_NNS discussed_VBN above_IN ,_,
        site-directed_JJ mutagenesis_NNS studies_NNS were_VBD conducted_VBN on_IN
        metallo-β-lactamase_JJ L_NNP 1_CD and_CC reported_VBD herein_NN ._.
        The_DT overlap_VB extension_NN method_NN [_NN 60_CD ]_NN was_VBD used_VBN to_TO prepare_VB
        the_DT site-directed_JJ mutants_NNS ,_, and_CC a_DT variety_NN of_IN studies_NNS were_VBD
        used_VBN to_TO probe_VB whether_IN the_DT single_JJ point_NN mutations_NNS resulted_VBD
        in_IN large_JJ structural_JJ changes_NNS in_IN the_DT mutant_JJ enzymes_NNS ._. (_( 1_LS )_) The_DT
        over-expression_JJ levels_NNS of_IN mutants_NNS were_VBD analyzed_VBN with_IN
        SDS-PAGE_NNP to_TO ensure_VB that_IN the_DT mutations_NNS did_VBD not_RB result_VB in_IN
        changes_NNS in_IN the_DT over-expression_JJ levels_NNS of_IN the_DT enzymes_NNS ._. With_IN
        a_DT few_JJ L_NNP 1_CD mutants_NNS and_CC with_IN other_JJ enzyme_NN systems_NNS in_IN the_DT lab_NN ,_,
        single_JJ point_NN mutations_NNS often_RB result_VBP in_IN depressed_VBN levels_NNS of_IN
        over-expression_JJ [_NN 61_CD ]_NN ._. In_IN the_DT case_NN of_IN the_DT mutants_NNS
        described_VBD here_RB ,_, all_DT of_IN the_DT mutants_NNS over-expressed_JJ at_IN levels_NNS
        comparable_JJ to_TO wild-type_JJ L_NNP 1_CD (_( data_NNS not_RB shown_VBN )_) ._. (_( 2_LS )_) The_DT total_JJ
        amounts_NNS of_IN the_DT mutants_NNS isolatable_JJ after_IN chromatography_NN were_VBD
        compared_VBN with_IN wild-type_JJ L_NNP 1_CD levels_NNS ._. We_PRP have_VBP found_VBN ,_, in_IN
        particular_JJ with_IN metal_NN binding_JJ mutants_NNS of_IN L_NNP 1_CD (_( G_NNP ._. Periyannan_NNP ,_,
        R_NN ._. B_NNP ._. Yates_NNP ,_, and_CC M_NNP ._. W_NNP ._. Crowder_NNP ,_, unpublished_JJ results_NNS )_) and_CC
        glyoxalase_NN II_NNP [_NN 61_CD ]_NN ,_, that_IN single_JJ point_NN mutations_NNS can_MD
        result_VB in_IN over-expressed_JJ mutants_NNS being_VBG processed_VBN into_IN
        inclusion_NN bodies_NNS and_CC unisolatable_JJ as_IN soluble_JJ proteins_NNS ._. In_IN
        the_DT case_NN of_IN the_DT mutants_NNS described_VBD here_RB ,_, all_DT of_IN the_DT mutants_NNS
        were_VBD isolated_VBN at_IN levels_NNS comparable_JJ to_TO wild-type_JJ L_NNP 1_CD ._. (_( 3_LS )_) CD_NNP
        spectra_NN were_VBD collected_VBN for_IN all_DT mutants_NNS and_CC compared_VBN to_TO the_DT
        spectrum_NN of_IN wild-type_JJ L_NNP 1_CD ._. Although_IN we_PRP did_VBD not_RB expect_VB a_DT
        large_JJ change_NN in_IN the_DT secondary_JJ structure_NN of_IN L_NNP 1_CD upon_IN single_JJ
        point_NN mutations_NNS ,_, CD_NNP spectroscopy_NN is_VBZ the_DT most_RBS common_JJ
        structural_JJ technique_NN to_TO characterize_VB site-directed_JJ mutants_NNS ._.
        All_DT of_IN the_DT mutants_NNS described_VBD here_RB exhibited_VBN CD_NNP spectra_NN that_WDT
        were_VBD very_RB similar_JJ ,_, or_CC identical_JJ ,_, to_TO that_DT of_IN wild-type_JJ L_NNP 1_CD
        (_( see_VB Additional_JJ file_NN 1_CD :_: CD_NNP spectra_NN )_) ._. (_( 4_LS )_) Metal_NNP analyses_NNS on_IN
        the_DT mutants_NNS were_VBD used_VBN to_TO probe_VB whether_IN point_NN mutations_NNS
        caused_VBD a_DT significant_JJ change_NN to_TO the_DT metal_NN binding_JJ site_NN as_IN to_TO
        preclude_VB metal_NN binding_JJ ._. The_DT crystal_NN structures_NNS of_IN the_DT
        metallo-β-lactamases_JJ reveal_VB a_DT complex_JJ and_CC far-reaching_JJ
        hydrogen-bonding_JJ network_NN around_IN the_DT metal_NN binding_JJ sites_NNS ,_,
        and_CC disruption_NN of_IN this_DT network_NN is_VBZ predicted_VBN to_TO affect_VB metal_NN
        binding_JJ [_NN 37_CD 42_CD 44_CD 45_CD 48_CD 49_CD 62_CD 63_CD ]_NN ._. With_IN all_DT of_IN the_DT
        mutants_NNS described_VBD here_RB except_IN the_DT S_NNP 224_CD K_NNP mutant_JJ ,_, each_DT mutant_JJ
        binds_NNS wild-type_JJ or_CC near-wild-type_JJ levels_NNS of_IN Zn_NNP (_( II_NNP )_) after_IN
        purification_NN ._. The_DT S_NNP 224_CD K_NNP mutant_JJ exhibited_VBN a_DT 50_CD %_NN reduction_NN in_IN
        metal_NN binding_JJ (_( Table_NNP 2_LS )_) ,_, and_CC we_PRP postulate_NN this_DT is_VBZ due_JJ to_TO
        electrostatic_JJ repulsions_NNS between_IN the_DT newly_RB introduced_VBN Lys_NNP
        with_IN Zn_NNP 
        2_CD ._. In_IN spite_NN of_IN the_DT mutants_NNS binding_JJ
        significant_JJ amounts_NNS of_IN Zn_NNP (_( II_NNP )_) ,_, we_PRP included_VBD 100_CD μM_NN ZnCl_NNP 
        2_CD in_IN all_DT of_IN the_DT kinetic_JJ buffers_NNS to_TO
        ensure_VB saturation_NN of_IN the_DT metal_NN binding_JJ sites_NNS and_CC to_TO
        facilitate_VB direct_JJ comparison_NN of_IN the_DT kinetic_JJ data_NN ._. (_( 5_LS )_) All_DT
        mutants_NNS were_VBD stable_JJ to_TO multiple_JJ freeze_NN /_NN thaw_NN cycles_NNS and_CC to_TO
        prolonged_JJ storage_NN (_( >_NN 3_CD weeks_NNS )_) at_IN 4_CD °_NN C_NNP ,_, retaining_VBG >_NN 95_CD %_NN
        of_IN their_PRP$ activity_NN ._. With_IN these_DT five_CD lines_NNS of_IN evidence_NN ,_, we_PRP
        were_VBD confident_JJ that_DT none_NN of_IN the_DT point_NN mutations_NNS resulted_VBD in_IN
        large_JJ structural_JJ changes_NNS in_IN L_NNP 1_CD and_CC that_IN any_DT kinetic_JJ
        differences_NNS could_MD be_VB attributed_VBN to_TO the_DT changed_VBN amino_JJ
        acid_NN ._.
        As_IN a_DT first_JJ approximation_NN of_IN substrate_NN binding_JJ ,_, we_PRP
        examined_VBD the_DT steady-state_JJ kinetics_NNS of_IN 4_CD cephalosporins_NNS ,_, 2_CD
        penicillins_NNS ,_, and_CC 3_CD carbapenems_NNS (_( Tables_NNP 3_CD ,_, 4_CD ,_, 5_LS )_) and_CC
        compared_VBD the_DT K_NNP 
        m_NN values_NNS of_IN the_DT mutants_NNS with_IN those_DT of_IN
        wild-type_JJ L_NNP 1_CD ._. The_DT substrates_NNS tested_VBN were_VBD chosen_VBN because_IN
        they_PRP exhibited_VBN low_JJ K_NNP 
        m_NN values_NNS in_IN previous_JJ kinetic_JJ studies_NNS [_NN
        36_CD ]_NN ,_, and_CC we_PRP believed_VBD that_IN we_PRP could_MD saturate_VB the_DT enzymes_NNS
        with_IN substrate_NN even_RB if_IN there_EX was_VBD large_JJ change_NN in_IN binding_VBG
        with_IN the_DT point_NN mutations_NNS ._. The_DT Tyr_NNP 228_CD mutants_NNS exhibited_VBN
        increased_VBN K_NNP 
        m_NN values_NNS for_IN 8_CD of_IN the_DT 9_CD substrates_NNS
        tested_VBN ,_, with_IN the_DT smallest_JJS changes_NNS in_IN K_NNP 
        m_NN observed_VBD when_WRB the_DT carbapenems_NNS were_VBD
        used_VBN as_IN the_DT substrate_NN ._. This_DT result_NN supports_VBZ the_DT proposed_VBN
        role_NN of_IN Tyr_NNP 228_CD in_IN substrate_NN binding_JJ ._. In_IN contrast_NN ,_, the_DT
        results_NNS on_IN the_DT Ser_NNP 224_CD mutants_NNS suggest_VBP that_IN this_DT residue_NN is_VBZ
        not_RB important_JJ in_IN substrate_NN binding_JJ ,_, since_IN the_DT S_NNP 224_CD A_DT and_CC
        S_NNP 224_CD K_NNP mutants_NNS did_VBD not_RB exhibit_VB any_DT significant_JJ increases_NNS (_( by_IN
        a_DT factor_NN of_IN ≥_NN 10_CD )_) in_IN K_NNP 
        m_NN for_IN any_DT of_IN the_DT substrates_NNS tested_VBN ._. Only_RB
        when_WRB Ser_NNP 224_CD was_VBD replaced_VBN with_IN an_DT Asp_NNP residue_NN was_VBD there_EX
        significant_JJ increases_NNS in_IN the_DT observed_VBN K_NNP 
        m_NN value_NN for_IN 6_CD of_IN the_DT 9_CD substrates_NNS
        tested_VBN ,_, and_CC the_DT largest_JJS changes_NNS were_VBD exhibited_VBN when_WRB the_DT
        penicillins_NNS were_VBD used_VBN as_IN substrates_NNS ._. This_DT result_NN supports_VBZ
        the_DT observation_NN of_IN differential_NN binding_JJ modes_NNS of_IN substrates_NNS
        to_TO the_DT β-lactamases_JJ ,_, depending_VBG on_IN the_DT structure_NN of_IN the_DT
        substrate_NN [_NN 43_CD 64_CD 65_CD ]_NN ._. The_DT only_RB remaining_VBG mutants_NNS that_WDT
        exhibited_VBN significant_JJ changes_NNS in_IN the_DT K_NNP 
        m_NN values_NNS were_VBD the_DT I_PRP 164_CD A_DT and_CC F_NN 158_CD A_DT
        mutants_NNS ._. The_DT I_PRP 164_CD A_DT mutant_JJ exhibited_VBN increased_VBN K_NNP 
        m_NN values_NNS only_RB when_WRB using_VBG cefoxitin_NN as_IN
        the_DT substrate_NN ,_, suggesting_VBG an_DT interaction_NN of_IN the_DT isoleucine_NN
        group_NN with_IN the_DT methoxy_NN group_NN on_IN cefoxitin_NN ._. The_DT F_NN 158_CD A_DT mutant_JJ
        exhibited_VBN higher_JJR K_NNP 
        m_NN values_NNS when_WRB using_VBG the_DT cephalosporins_NNS
        as_IN substrates_NNS ,_, suggesting_VBG an_DT interaction_NN of_IN the_DT
        cephalosporins_NNS '_POS substituents_NNS with_IN the_DT phenylalanine_NN on_IN the_DT
        loop_NN that_WDT extends_VBZ over_IN the_DT active_JJ site_NN ._. None_NN of_IN the_DT other_JJ
        mutants_NNS exhibited_VBN vastly_RB different_JJ values_NNS for_IN K_NNP 
        m_NN with_IN any_DT of_IN the_DT substrates_NNS tested_VBN ._.
        An_DT examination_NN of_IN the_DT 
        k_NN 
        cat_NN values_NNS of_IN the_DT mutants_NNS revealed_VBD some_DT
        surprising_JJ results_NNS ._. The_DT S_NNP 224_CD D_NNP mutants_NNS displayed_VBN decreased_VBD 
        k_NN 
        cat_NN values_NNS for_IN 7_CD of_IN the_DT 9_CD substrates_NNS
        tested_VBN ._. Since_IN similar_JJ results_NNS were_VBD not_RB observed_VBN with_IN the_DT
        S_NNP 224_CD K_NNP and_CC S_NNP 224_CD A_DT mutants_NNS ,_, we_PRP do_VBP not_RB propose_VB a_DT catalytic_JJ role_NN
        for_IN Ser_NNP 224_CD ._. Instead_RB ,_, we_PRP predict_VBP that_IN the_DT insertion_NN of_IN an_DT
        aspartic_JJ acid_NN into_IN the_DT active_JJ site_NN at_IN position_NN 224_CD results_NNS
        in_IN a_DT change_NN in_IN the_DT hydrogen_NN bonding_NN network_NN in_IN L_NNP 1_CD ;_: this_DT
        hydrogen_NN bonding_NN network_NN is_VBZ extensive_JJ in_IN all_DT
        metallo-β-lactamases_JJ that_WDT have_VBP been_VBN characterized_VBN
        crystallographically_RB [_NN 37_CD 42_CD 44_CD 45_CD 48_CD 49_CD 62_CD 63_CD ]_NN ._. The_DT
        N_NNP 233_CD D_NNP mutant_JJ also_RB exhibited_VBN greatly_RB reduced_VBN 
        k_NN 
        cat_NN values_NNS for_IN biapenem_NN and_CC meropenem_NN
        but_CC not_RB for_IN imipenem_NN or_CC any_DT of_IN the_DT other_JJ substrates_NNS tested_VBN ._.
        This_DT mutation_NN is_VBZ also_RB predicted_VBN to_TO affect_VB the_DT hydrogen_NN
        bonding_NN network_NN around_IN the_DT active_JJ site_NN ,_, and_CC apparently_RB ,_,
        interactions_NNS of_IN the_DT enzyme_NN with_IN the_DT 4_CD '_POS substituent_NN of_IN the_DT
        carbapenems_NNS has_VBZ an_DT effect_NN on_IN catalysis_NNS ._. More_RBR surprisingly_RB
        are_VBP the_DT increases_NNS in_IN 
        k_NN 
        cat_NN of_IN the_DT F_NN 158_CD A_DT mutants_NNS ._. We_PRP are_VBP
        uncertain_JJ why_WRB the_DT mutation_NN of_IN residues_NNS on_IN the_DT loop_NN that_WDT
        extends_VBZ over_IN the_DT active_JJ site_NN would_MD affect_VB 
        k_NN 
        cat_NN ,_, since_IN substrate_NN and_CC product_NN
        binding_JJ have_VBP been_VBN predicted_VBN to_TO be_VB very_RB fast_RB in_IN the_DT reaction_NN
        of_IN nitrocefin_NN with_IN L_NNP 1_CD ._. However_RB ,_, we_PRP do_VBP note_VB that_IN the_DT k_NN 
        cat_NN /_NN K_NNP 
        m_NN values_NNS of_IN wild-type_JJ L_NNP 1_CD and_CC F_NN 158_CD A_DT
        differ_VB by_IN a_DT factor_NN less_JJR than_IN 2_CD ._.
        The_DT inability_NN to_TO propose_VB a_DT consistent_JJ binding_JJ model_NN also_RB
        supports_VBZ the_DT recent_JJ proposal_NN that_IN different_JJ substrates_NNS of_IN
        L_NNP 1_CD are_VBP hydrolyzed_JJ by_IN different_JJ mechanisms_NNS and_CC further_JJ
        suggests_VBZ that_IN using_VBG steady-state_JJ kinetic_JJ constants_NNS may_MD not_RB
        be_VB a_DT valid_JJ way_NN to_TO probe_VB substrate_NN binding_JJ to_TO L_NNP 1_CD ._. In_IN
        addition_NN ,_, the_DT minimal_JJ kinetic_JJ mechanism_NN of_IN nitrocefin_NN
        hydrolysis_NNS by_IN L_NNP 1_CD has_VBZ been_VBN reported_VBN ,_, and_CC this_DT mechanism_NN
        predicts_VBZ that_IN K_NNP 
        m_NN does_VBZ not_RB accurately_RB reflect_VB substrate_NN
        binding_JJ ._. By_IN using_VBG this_DT mechanism_NN [_NN 39_CD ]_NN ,_, K_NNP 
        m_NN is_VBZ equal_JJ to_TO {_( (_( k_NN 
        -_: 1_CD +_NN k_NN 
        2_LS )_) k_NN 
        3_CD k_NN 
        4_LS }_) /_NN {_( k_NN 
        1_CD (_( k_NN 
        3_CD k_NN 
        4_CD +_NN k_NN 
        2_CD k_NN 
        4_CD +_NN k_NN 
        2_CD k_NN 
        3_LS }_) ._. To_TO probe_VB more_RBR directly_RB the_DT
        reaction_NN ,_, stopped-flow_JJ absorbance_NN studies_NNS were_VBD conducted_VBN ,_,
        and_CC the_DT substrate_NN decay_NN rates_NNS (_( 390_CD nm_NN )_) were_VBD studied_VBN as_IN a_DT
        function_NN of_IN nitrocefin_NN concentration_NN ._. While_IN nitrocefin_NN is_VBZ a_DT
        nontypical_JJ substrate_NN ,_, as_IN a_DT result_NN of_IN the_DT
        dinitro-substituted_JJ styryl_NN substituent_NN [_NN 40_CD ]_NN ,_, it_PRP is_VBZ the_DT
        substrate_NN about_IN which_WDT the_DT most_JJS is_VBZ known_VBN about_IN its_PRP$
        hydrolysis_NNS mechanism_NN ._. Therefore_RB ,_, kinetic_JJ studies_NNS with_IN
        nitrocefin_NN as_IN substrate_NN allowed_VBN for_IN us_PRP to_TO evaluate_VB the_DT
        effect_NN of_IN point_NN mutations_NNS on_IN the_DT reaction_NN mechanism_NN of_IN L_NNP 1_CD ._.
        There_EX was_VBD no_DT clear_JJ dependence_NN on_IN substrate_NN decay_NN rates_NNS with_IN
        nitrocefin_NN concentration_NN (_( data_NNS not_RB shown_VBN )_) ._. We_PRP did_VBD note_NN
        though_IN that_IN the_DT amount_NN of_IN intermediate_JJ formed_VBN during_IN the_DT
        reactions_NNS varied_VBD considerably_RB depending_VBG upon_IN which_WDT mutant_JJ
        of_IN L_NNP 1_CD was_VBD used_VBN in_IN the_DT study_NN ._. All_DT of_IN the_DT mutants_NNS exhibited_VBN
        decreases_NNS in_IN intermediate_JJ formation_NN ,_, and_CC the_DT S_NNP 224_CD D_NNP ,_, S_NNP 224_CD K_NNP ,_,
        F_NN 158_CD A_DT ,_, N_NNP 233_CD D_NNP ,_, and_CC N_NNP 233_CD L_NNP mutants_NNS yielded_VBD rapid-scanning_JJ data_NNS
        consistent_JJ with_IN no_DT detectable_JJ intermediate_JJ ._. These_DT same_JJ
        mutants_NNS exhibited_VBN vastly_RB differing_VBG K_NNP 
        m_NN values_NNS ._. Clearly_RB there_EX is_VBZ no_DT
        correlation_NN of_IN K_NNP 
        m_NN with_IN the_DT presence_NN of_IN the_DT reaction_NN
        intermediate_JJ ._. Apparently_RB ,_, the_DT ability_NN to_TO observe_VB the_DT
        intermediate_JJ is_VBZ not_RB governed_VBN entirely_RB by_IN the_DT choice_NN of_IN
        substrate_NN [_NN 40_CD ]_NN ,_, and_CC it_PRP also_RB depends_VBZ on_IN precise_JJ
        arrangement_NN of_IN active_JJ site_NN residues_NNS ._. It_PRP is_VBZ also_RB possible_JJ
        that_IN the_DT site-directed_JJ mutants_NNS could_MD be_VB utilizing_VBG a_DT
        different_JJ mechanism_NN to_TO hydrolyze_NN nitrocefin_NN [_NN 66_CD ]_NN ._.
        Recently_RB ,_, Spencer_NNP and_CC co-workers_NNS reported_VBD that_IN
        stopped-flow_JJ fluorescence_NN studies_NNS can_MD be_VB used_VBN to_TO monitor_VB
        the_DT reaction_NN of_IN L_NNP 1_CD with_IN nitrocefin_NN and_CC that_IN an_DT initial_JJ
        binding_JJ step_NN can_MD be_VB directly_RB monitored_VBN [_NN 40_CD ]_NN ._. By_IN
        increasing_VBG the_DT concentration_NN of_IN nitrocefin_NN ,_, the_DT rate_NN of_IN the_DT
        initial_JJ binding_JJ step_NN increased_VBD to_TO a_DT maximum_NN ,_, and_CC fitting_NN of_IN
        these_DT data_NNS yielded_VBD a_DT binding_JJ constant_JJ (_( called_VBN K_NNP 
        S_NNP herein_NN )_) for_IN nitrocefin_NN ._. Each_DT of_IN the_DT L_NNP 1_CD
        mutants_NNS were_VBD studied_VBN using_VBG the_DT stopped-flow_JJ fluorescence_NN
        studies_NNS ,_, and_CC the_DT resulting_VBG data_NN were_VBD fitted_JJ as_IN reported_VBN by_IN
        Spencer_NNP 
        et_CC al_NN ._. [_NN 40_CD ]_NN (_( Table_NNP 6_CD )_) ._. All_DT of_IN the_DT
        mutants_NNS exhibited_VBN K_NNP 
        S_NNP values_NNS identical_JJ ,_, within_IN error_NN ,_, to_TO
        wild-type_JJ L_NNP 1_CD ,_, except_IN the_DT S_NNP 224_CD D_NNP and_CC the_DT Y_NNP 228_CD A_DT mutants_NNS ._. The_DT
        placement_NN of_IN a_DT negative_JJ charge_NN at_IN position_NN 224_CD drastically_RB
        affects_VBZ nitrocefin_NN binding_JJ and_CC results_NNS in_IN a_DT 6_CD -_: fold_VB decrease_VB
        in_IN binding_JJ affinity_NN (_( Table_NNP 6_CD )_) ._. To_TO a_DT lesser_JJR degree_NN ,_, the_DT
        aromatic_JJ portion_NN of_IN Tyr_NNP 228_CD must_MD have_VB an_DT effect_NN on_IN the_DT
        binding_JJ site_NN as_IN the_DT K_NNP 
        S_NNP value_NN for_IN nitrocefin_NN binding_VBG to_TO this_DT
        mutant_JJ is_VBZ decreased_VBN by_IN a_DT factor_NN of_IN 2_CD ;_: however_RB ,_, the_DT hydroxyl_NN
        group_NN probably_RB does_VBZ not_RB form_VB a_DT hydrogen_NN bond_NN to_TO the_DT
        substrate_NN as_IN proposed_VBN ._. By_IN using_VBG nitrocefin_NN as_IN substrate_NN and_CC
        K_NNP 
        m_NN values_NNS alone_RB ,_, a_DT completely_RB different_JJ
        conclusion_NN is_VBZ reached_VBN regarding_VBG important_JJ substrate_NN binding_JJ
        residues_NNS ._. The_DT results_NNS presented_VBN here_RB suggests_VBZ that_DT none_NN of_IN
        the_DT residues_NNS in_IN this_DT study_NN are_VBP essential_JJ for_IN tight_JJ
        nitrocefin_NN binding_JJ ,_, possibly_RB because_IN other_JJ parts_NNS of_IN the_DT
        active_JJ site_NN accommodate_VBP the_DT loss_NN of_IN certain_JJ binding_JJ
        contacts_NNS ._.
        Spencer_NNP 
        et_CC al_NN ._. also_RB reported_VBD stopped-flow_JJ
        fluorescence_NN studies_NNS when_WRB using_VBG cefaclor_NN and_CC meropenem_NN as_IN
        substrates_NNS ,_, and_CC K_NNP 
        S_NNP values_NNS for_IN these_DT substrates_NNS were_VBD
        reported_VBN to_TO be_VB 710_CD ±_NN 180_CD and_CC 272_CD ±_NN 112_CD μM_NN ,_, respectively_RB [_NN
        40_CD ]_NN ._. However_RB in_IN our_PRP$ hands_NNS ,_, the_DT rates_NNS of_IN substrate_NN
        hydrolysis_NNS were_VBD so_RB fast_RB when_WRB using_VBG wild-type_JJ L_NNP 1_CD that_IN we_PRP
        could_MD not_RB use_VB substrate_NN concentrations_NNS high_JJ enough_RB to_TO
        saturate_VB the_DT enzyme_NN ._. Similarly_RB ,_, we_PRP could_MD not_RB determine_VB K_NNP 
        S_NNP values_NNS for_IN penicillin_NN G_NNP or_CC ampicillin_NN
        because_IN the_DT observed_VBN rates_NNS of_IN hydrolysis_NNS at_IN low_JJ substrate_NN
        concentrations_NNS were_VBD too_RB fast_RB to_TO observe_VB data_NNS ,_, even_RB at_IN
        10_CD °_NN C_NNP ._.
      
      
        Conclusions_NNP
        The_DT results_NNS presented_VBD herein_NN indicate_VBP that_DT none_NN of_IN the_DT
        active_JJ site_NN residues_NNS identified_VBN with_IN computational_NN studies_NNS
        are_VBP essential_JJ for_IN tight_JJ substrate_NN binding_JJ ._. These_DT data_NNS also_RB
        indicate_VBP that_IN the_DT use_NN of_IN K_NNP 
        m_NN values_NNS to_TO describe_VB substrate_NN binding_JJ
        to_TO L_NNP 1_CD is_VBZ unreliable_JJ and_CC that_IN there_EX is_VBZ no_DT correlation_NN
        between_IN intermediate_JJ accumulation_NN and_CC substrate_NN binding_JJ
        affinity_NN ._. These_DT results_NNS demonstrate_VBP that_IN new_JJ computational_NN
        studies_NNS are_VBP now_RB needed_VBN to_TO probe_VB substrate_NN binding_JJ to_TO L_NNP 1_CD ,_,
        and_CC these_DT studies_NNS are_VBP currently_RB underway_NN ._. The_DT results_NNS
        presented_VBD herein_NN can_MD be_VB used_VBN to_TO guide_VB these_DT new_JJ
        computational_NN studies_NNS ,_, which_WDT will_MD lead_VB to_TO the_DT design_NN of_IN
        potential_JJ inhibitors_NNS and_CC hopefully_RB a_DT way_NN to_TO combat_VB
        penicillin_NN resistance_NN in_IN bacteria_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS
          
          E_NNP ._. coli_NNS strains_NNS DH_NNP 5_CD α_NN and_CC BL_NNP 21_CD (_( DE_NNP 3_LS )_)
          pLysS_NN were_VBD obtained_VBN from_IN Gibco_NNP BRL_NNP and_CC Novagen_NNP ,_,
          respectively_RB ._. Plasmids_NNP pET_NN 26_CD b_SYM and_CC pUC_NN 19_CD were_VBD purchased_VBN
          from_IN Novagen_NNP ._. Primers_NNP for_IN sequencing_VBG and_CC mutagenesis_NNS
          studies_NNS were_VBD purchased_VBN from_IN Integrated_NNP DNA_NNP Technologies_NNPS ._.
          Deoxynucleotide_NNP triphosphates_NNS (_( dNTP_NN 's_POS )_) ,_, MgSO_NNP 
          4_CD ,_, thermopol_NN buffer_NN ,_, Deep_NNP Vent_NNP DNA_NNP
          polymerase_NN ,_, and_CC restrictions_NNS enzymes_NNS were_VBD purchased_VBN from_IN
          Promega_NNP or_CC New_NNP England_NNP Biolabs_NNP ._. Polymerase_NNP chain_NN reaction_NN
          was_VBD conducted_VBN using_VBG a_DT Thermolyne_NNP Amplitron_NNP II_NNP unit_NN ._. DNA_NNP
          was_VBD purified_JJ using_VBG the_DT Qiagen_NNP QIAQuick_NNP gel_NN extraction_NN kit_NN
          or_CC Plasmid_NNP Purification_NNP kit_NN with_IN QIAGEN-tip_NNP 100_CD (_( Midi_NNP )_)
          columns_NNS ._. Wizard_NNP Plus_NNP Minipreps_NNP were_VBD acquired_VBN from_IN
          Promega_NNP ._. Luria-_NNP Bertani_NNP (_( LB_NNP )_) media_NNS was_VBD made_VBN following_VBG
          published_VBN procedures_NNS [_NN 67_CD ]_NN ._. Isopropyl-β-thiogalactoside_NNP
          (_( IPTG_NNP )_) ,_, Biotech_NNP grade_NN ,_, was_VBD procured_JJ from_IN Anatrace_NNP ._.
          Phenylmethylsulfonylfluoride_NNP (_( PMSF_NNP )_) was_VBD purchased_VBN from_IN
          Sigma_NNP ._. Protein_NNP solutions_NNS were_VBD concentrated_VBN with_IN an_DT Amicon_NNP
          ultrafiltration_NN cell_NN equipped_VBN with_IN YM-_NNP 10_CD DIAFLO_NNP membranes_NNS
          from_IN Amicon_NNP ,_, Inc_NNP ._. Dialysis_NNP tubing_VBG was_VBD prepared_VBN using_VBG
          Spectra_NNP /_NN Por_NNP regenerated_JJ cellulose_NN molecular_JJ porous_JJ
          membranes_NNS with_IN a_DT molecular_JJ weight_NN cut-off_JJ of_IN 6_CD -_: 8_CD ,_, 000_CD
          g_SYM /_NN mol_NN ._. Q-S_NNP epharose_NN Fast_NNP Flow_NNP was_VBD purchased_VBN from_IN Amersham_NNP
          Pharmacia_NNP Biotech_NNP ._. Nitrocefin_NNP was_VBD purchased_VBN from_IN Becton_NNP
          Dickinson_NNP ,_, and_CC solutions_NNS of_IN nitrocefin_NN were_VBD filtered_VBN
          through_IN a_DT Fisherbrand_NNP 0_CD ._. 45_CD micron_NN syringe_NN filter_NN ._.
          Cefaclor_NNP ,_, cefoxitin_NN ,_, and_CC cephalothin_NN were_VBD purchased_VBN from_IN
          Sigma_NNP ;_: penicillin_NN G_NNP and_CC ampicillin_NN were_VBD purchased_VBN from_IN
          Fisher_NNP ._. Imipenem_NNP ,_, meropenem_NN ,_, and_CC biapenem_NN were_VBD generously_RB
          supplied_VBN by_IN Merck_NNP ,_, Zeneca_NNP Pharmaceuticals_NNP ,_, and_CC Lederle_NNP
          (_( Japan_NNP )_) ,_, respectively_RB ._. All_DT buffers_NNS and_CC media_NNS were_VBD
          prepared_VBN using_VBG Barnstead_NNP NANOpure_NNP ultrapure_NN water_NN ._.
        
        
          Generation_NNP of_IN site-directed_JJ mutants_NNS of_IN L_NNP 1_CD
          The_DT over-expression_JJ plasmid_NN for_IN L_NNP 1_CD ,_, pUB_NN 5832_CD ,_, was_VBD
          digested_VBN with_IN 
          Nde_NNP I_PRP and_CC 
          Hind_NNP III_NNP ,_, and_CC the_DT resulting_VBG 
          ca_MD ._. 900_CD bp_NN piece_NN was_VBD gel_NN purified_JJ
          and_CC ligated_JJ using_VBG T_NN 4_CD ligase_NN into_IN pUC_NN 19_CD ,_, which_WDT was_VBD also_RB
          digested_VBN with_IN 
          Nde_NNP I_PRP and_CC 
          Hind_NNP III_NNP ,_, to_TO yield_VB the_DT cloning_VBG
          plasmid_NN pL_NN 1_CD PUC_NNP 19_CD ._. Mutations_NNP were_VBD introduced_VBN into_IN the_DT L_NNP 1_CD
          gene_NN by_IN using_VBG the_DT overlap_VB extension_NN method_NN of_IN Ho_NNP 
          et_CC al_NN ._. [_NN 60_CD ]_NN ,_, as_IN described_VBN
          previously_RB [_NN 68_CD ]_NN ._. The_DT oligonucleotides_NNS used_VBN for_IN the_DT
          preparation_NN of_IN the_DT mutants_NNS are_VBP shown_VBN in_IN Table_NNP 1_CD ._. The_DT 
          ca_MD ._. 900_CD bp_NN PCR_NNP products_NNS were_VBD
          digested_VBN with_IN 
          Nde_NNP I_PRP and_CC 
          Hind_NNP III_NNP and_CC ligated_JJ into_IN pUC_NN 19_CD ._.
          The_DT DNA_NNP sequences_NNS were_VBD analyzed_VBN by_IN the_DT Biosynthesis_NNP and_CC
          Sequencing_NNP Facility_NNP in_IN the_DT Department_NNP of_IN Biological_NNP
          Chemistry_NNP at_IN Johns_NNP Hopkins_NNP University_NNP ._. After_IN confirmation_NN
          of_IN the_DT sequence_NN ,_, the_DT mutated_VBN pL_NN 1_CD PUC_NNP 19_CD plasmid_NN was_VBD
          digested_VBN with_IN 
          Nde_NNP I_PRP and_CC 
          Hind_NNP III_NNP ,_, and_CC the_DT 900_CD bp_NN ,_, mutated_VBN
          L_NNP 1_CD gene_NN was_VBD gel_NN purified_JJ and_CC ligated_JJ into_IN pET_NN 26_CD b_SYM to_TO
          create_VB the_DT mutant_JJ overexpression_NN plasmids_NNS ._. To_TO test_VB for_IN
          overexpression_NN of_IN the_DT mutant_JJ enzymes_NNS ,_, 
          E_NNP ._. coli_NNS BL_NNP 21_CD (_( DE_NNP 3_LS )_) pLysS_NN cells_NNS were_VBD
          transformed_VBN with_IN the_DT mutated_VBN over-expression_JJ plasmids_NNS ,_,
          and_CC small_JJ scale_NN growth_NN cultures_NNS were_VBD used_VBN [_NN 68_CD ]_NN ._.
          Large-scale_NNP (_( 4_CD L_NNP )_) preparations_NNS of_IN the_DT L_NNP 1_CD mutants_NNS were_VBD
          performed_VBN as_IN described_VBN previously_RB [_NN 36_CD ]_NN ._. Protein_NNP purity_NN
          was_VBD ascertained_JJ by_IN SDS-PAGE_NNP ._.
        
        
          Metal_NN content_NN
          The_DT concentrations_NNS of_IN L_NNP 1_CD and_CC the_DT mutants_NNS were_VBD
          determined_VBN by_IN measuring_VBG the_DT proteins_NNS '_POS absorbance_NN at_IN 280_CD
          nm_NN and_CC using_VBG the_DT published_VBN extinction_NN coefficient_NN of_IN ε_NN 
          280_CD nm_NN =_SYM 54_CD ,_, 804_CD M_NNP -_: 1_CD •_NN cm_NN -_: 1_CD [_NN 36_CD ]_NN or_CC
          by_IN using_VBG the_DT method_NN of_IN Pace_NNP [_NN 69_CD ]_NN ._. Before_IN metal_NN
          analyses_NNS ,_, the_DT protein_NN samples_NNS were_VBD dialyzed_JJ versus_CC 3_CD ×_NN 1_CD
          L_NNP of_IN metal-free_JJ ,_, 50_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 5_CD over_IN 96_CD hours_NNS at_IN
          4_CD °_NN C_NNP ._. A_DT Varian_NNP Inductively_NNP Coupled_VBN Plasma_NNP Spectrometer_NNP
          with_IN atomic_JJ emission_NN spectroscopy_NN detection_NN (_( ICP-AES_NNP )_) was_VBD
          used_VBN to_TO determine_VB metal_NN content_NN of_IN multiple_JJ preparations_NNS
          of_IN wild_JJ type_NN L_NNP 1_CD and_CC L_NNP 1_CD mutants_NNS ._. Calibration_NNP curves_NNS were_VBD
          based_VBN on_IN three_CD standards_NNS and_CC had_VBD correlation_NN coefficient_NN
          limits_NNS of_IN at_IN least_JJS 0_CD ._. 9950_CD ._. The_DT final_JJ dialysis_NN buffer_NN was_VBD
          used_VBN as_IN a_DT blank_NN ,_, and_CC the_DT Zn_NNP (_( II_NNP )_) content_NN in_IN the_DT final_JJ
          dialysis_NN buffers_NNS was_VBD shown_VBN to_TO be_VB <_NN 0_CD ._. 5_CD μM_NN (_( detection_NN
          limit_NN of_IN ICP_NNP )_) in_IN separate_JJ ICP_NNP measurements_NNS ._. The_DT emission_NN
          line_NN of_IN 213_CD ._. 856_CD nm_NN is_VBZ the_DT most_RBS intense_JJ for_IN zinc_NN and_CC was_VBD
          used_VBN to_TO determine_VB the_DT Zn_NNP content_NN in_IN the_DT samples_NNS ._. The_DT
          errors_NNS in_IN metal_NN content_NN data_NNS reflect_VBP the_DT standard_JJ
          deviation_NN (_( σ_NN 
          n-_NN 1_LS )_) of_IN multiple_JJ enzyme_NN
          preparations_NNS ._.
        
        
          Steady-state_NNP kinetic_JJ studies_NNS
          Steady-state_NNP kinetic_JJ assays_NNS were_VBD conducted_VBN at_IN 25_CD °_NN C_NNP in_IN
          50_CD mM_NN cacodylate_NN buffer_NN ,_, pH_NN 7_CD ._. 0_CD ,_, containing_VBG 100_CD μM_NN ZnCl_NNP 
          2_CD on_IN a_DT HP_NNP 5480_CD A_DT diode_NN array_NN UV-Vis_NNP
          spectrophotometer_NN at_IN 25_CD °_NN C_NNP ._. The_DT changes_NNS in_IN molar_NN
          absorptivities_NNS (_( Δε_NN )_) used_VBN to_TO quantitate_NN products_NNS were_VBD (_( in_IN
          M_NNP -_: 1_CD cm_NN -_: 1_LS )_) :_: nitrocefin_NN ,_, Δε_NN 
          485_CD =_SYM 17_CD ,_, 420_CD ;_: cephalothin_NN ,_, Δε_NN 
          265_CD =_SYM -_: 8_CD ,_, 790_CD ;_: cefoxitin_NN ,_, Δε_NN 
          265_CD =_SYM -_: 7_CD ,_, 000_CD ;_: cefaclor_NN ,_, Δε_NN 
          280_CD =_SYM -_: 6_CD ,_, 410_CD ;_: imipenem_NN ,_, Δε_NN 
          300_CD =_SYM -_: 9_CD ,_, 000_CD ;_: meropenem_NN ,_, Δε_NN 
          293_CD =_SYM -_: 7_CD ,_, 600_CD ;_: biapenem_NN ,_, Δε_NN 
          293_CD =_SYM -_: 8_CD ,_, 630_CD ;_: ampicillin_NN ,_, Δε_NN 
          235_CD =_SYM -_: 809_CD ;_: and_CC penicillin_NN G_NNP ,_, Δε_NN 
          235_CD =_SYM -_: 936_CD ._. When_WRB possible_JJ ,_, substrate_NN
          concentrations_NNS were_VBD varied_VBN between_IN 0_CD ._. 1_CD to_TO 10_CD times_NNS the_DT K_NNP 
          m_NN value_NN ._. In_IN kinetic_JJ studies_NNS using_VBG
          substrates_NNS with_IN low_JJ K_NNP 
          m_NN values_NNS (_( cefoxitin_NN ,_, nitrocefin_NN ,_, and_CC
          cephalothin_NN )_) or_CC with_IN small_JJ Δε_NN values_NNS (_( penicillin_NN and_CC
          ampicillin_NN )_) ,_, we_PRP typically_RB used_VBD substrate_NN concentrations_NNS
          varied_VBD between_IN ~_NN K_NNP 
          m_NN and_CC 10_CD ×_NN K_NNP 
          m_NN and_CC used_VBN as_IN much_JJ of_IN the_DT ΔA_NN versus_CC
          time_NN data_NNS (_( that_WDT was_VBD linear_JJ )_) as_IN possible_JJ to_TO determine_VB the_DT
          velocity_NN ._. Steady-state_NNP kinetics_NNS constants_NNS ,_, K_NNP 
          m_NN and_CC 
          k_NN 
          cat_NN ,_, were_VBD determined_VBN by_IN fitting_JJ
          initial_JJ velocity_NN versus_CC substrate_NN concentration_NN data_NNS
          directly_RB to_TO the_DT Michaelis_NNP equation_NN using_VBG CurveFit_NNP [_NN 36_CD ]_NN
          ._. The_DT reported_VBD errors_NNS reflect_VBP fitting_JJ uncertainties_NNS ._. All_DT
          steady-state_JJ kinetic_JJ studies_NNS were_VBD performed_VBN in_IN triplicate_NN
          with_IN recombinant_JJ L_NNP 1_CD from_IN at_IN least_JJS three_CD different_JJ enzyme_NN
          preparations_NNS ._.
        
        
          Circular_NNP dichroism_NN
          Circular_NNP dichroism_NN samples_NNS were_VBD prepared_VBN by_IN dialyzing_VBG
          the_DT purified_JJ enzyme_NN samples_NNS versus_CC 3_CD ×_NN 2_CD L_NNP of_IN 5_CD mM_NN
          phosphate_NN buffer_NN ,_, pH_NN 7_CD ._. 0_CD over_IN six_CD hours_NNS ._. The_DT samples_NNS were_VBD
          diluted_VBN with_IN final_JJ dialysis_NN buffer_NN to_TO ~_NN 75_CD μg_NN /_NN mL_NN ._. A_DT JASCO_NNP
          J-_NNP 810_CD CD_NNP spectropolarimeter_NN operating_VBG at_IN 25_CD °_NN C_NNP was_VBD used_VBN to_TO
          collect_VB CD_NNP spectra_NN ._.
        
        
          Stopped_NNP -_: flow_NN /_NN Rapid-_NNP Scanning_NNP UV-Visible_NNP
          Spectrophotometry_NNP
          Rapid-scanning_NNP Vis_NNP spectra_NN of_IN nitrocefin_NN hydrolysis_NNS by_IN
          L_NNP 1_CD and_CC the_DT L_NNP 1_CD mutants_NNS were_VBD collected_VBN on_IN a_DT Applied_NNP
          Photophysics_NNP SX_NNP ._. 18_CD MV_NNP stopped-flow_JJ spectrophotometer_NN
          equipped_VBN with_IN an_DT Applied_NNP Photophysics_NNP PD_NNP ._. l_NN photodiode_NN
          array_NN detector_NN and_CC a_DT 1_CD cm_NN pathlength_NN optical_JJ cell_NN ._. A_DT
          typical_JJ experiment_NN consisted_VBD of_IN 25_CD μM_NN enzyme_NN and_CC 5_CD μM_NN
          nitrocefin_NN in_IN 50_CD mM_NN cacodylate_NN buffer_NN ,_, pH_NN 7_CD ._. 0_CD containing_VBG
          100_CD μM_NN ZnCl_NNP 
          2_CD ,_, the_DT reaction_NN temperature_NN was_VBD
          thermostated_JJ at_IN 25_CD °_NN C_NNP ,_, and_CC the_DT spectra_NN were_VBD collected_VBN
          between_IN 300_CD and_CC 725_CD nm_NN ._. Data_NNS from_IN at_IN least_JJS three_CD
          experiments_NNS were_VBD collected_VBN and_CC averaged_VBN ._. Absorbance_NNP data_NNS
          were_VBD converted_VBN to_TO concentration_NN data_NNS as_IN described_VBN
          previously_RB by_IN McMannus_NNP and_CC Crowder_NNP [_NN 39_CD ]_NN ._. Stopped-flow_NNP
          fluorescence_NN studies_NNS of_IN nitrocefin_NN hydrolysis_NNS by_IN L_NNP 1_CD were_VBD
          performed_VBN on_IN an_DT Applied_NNP Photophysics_NNP SX_NNP ._. 18_CD MV_NNP
          spectrophotometer_NN ,_, using_VBG an_DT excitation_NN wavelength_NN of_IN 295_CD
          nm_NN and_CC a_DT WG_NNP 320_CD nm_NN cut-off_JJ filter_NN on_IN the_DT photomultiplier_NN ._.
          These_DT experiments_NNS were_VBD conducted_VBN at_IN 10_CD °_NN C_NNP using_VBG the_DT same_JJ
          buffer_NN in_IN the_DT rapid-scanning_JJ Vis_NNP studies_NNS ._. Fluorescence_NNP
          data_NNS were_VBD fitted_JJ to_TO 
          k_NN 
          obs_NNS =_SYM {_( (_( 
          k_NN 
          f_SYM [_NN S_NNP ]_NN )_) /_NN K_NNP 
          S_NNP +_NN [_NN S_NNP ]_NN )_) }_) +_NN 
          k_NN 
          r_LS as_IN described_VBN previously_RB [_NN 40_CD ]_NN or_CC to_TO
          
          k_NN 
          obs_NNS =_SYM 
          k_NN 
          f_SYM [_NN S_NNP ]_NN +_NN 
          k_NN 
          r_LS by_IN using_VBG CurveFit_NNP v_NN ._. 1_CD ._. 0_CD ._.
        
      
      
        Abbreviations_NNP
        AES_NNP ,_, atomic_JJ emission_NN spectroscopy_NN ;_: bp_NN ,_, base_NN pairs_NNS ;_: CD_NNP ,_,
        circular_JJ dichroism_NN ;_: ε_NN ,_, extinction_NN coefficient_NN ;_: ICP_NNP ,_,
        inductively_RB coupled_VBN plasma_NN ;_: 
        k_NN 
        cat_NN ,_, turnover_NN number_NN ;_: kDa_NN ,_, kilodaltons_NNS ;_:
        K_NNP 
        m_NN ,_, Michaelis_NNP constant_JJ ;_: K_NNP 
        S_NNP ,_, substrate_NN binding_JJ constant_JJ ;_: LB_NNP ,_,
        Luria-_NNP Bertani_NNP media_NNS ._.
      
    
  
